TradeLegend的个人主页 - 老虎社区

TradeLegend

TradeLegend

暂无个人介绍

IP属地：未知

7关注

10粉丝

0主题

0勋章

2021-12-21

🤑

抱歉，原内容已删除

2021-12-20

🤑

Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>

2021-12-18

🤑

DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>

2021-12-17

🤑

Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain<blockquote>Adagio Therapeutics继续其狂野之旅——两项测试如何带来三位数的收益</blockquote>

2021-12-16

🤑

All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>

2021-12-15

🤑

抱歉，原内容已删除

2021-12-14

🤑

抱歉，原内容已删除

2021-12-13

🤑

Stock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote>

2021-12-13

🤑

抱歉，原内容已删除

2021-12-11

🤑

Tesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote>

2021-12-09

🤑

抱歉，原内容已删除

2021-12-08

🤑

Alibaba shares fell nearly 5% in Hong Kong market<blockquote>阿里巴巴-SW股价在香港市场下跌近5%</blockquote>

2021-12-07

🤑

Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>

2021-12-03

🤑

抱歉，原内容已删除

2021-12-01

🤑

抱歉，原内容已删除

2021-11-30

🤑

Roku’s Beaten-Down Stock Is Still a Winner, Analysts Say<blockquote>分析师表示，Roku遭受重创的股票仍然是赢家</blockquote>

2021-11-29

🤑

IBM Cast Off Kyndryl. Here’s What Investors Should Do With the Stock<blockquote>IBM放弃了Kyndryl。以下是投资者应该如何处理该股票</blockquote>

2021-11-27

🤑

Amazon faces Black Friday strikes by workers across Europe<blockquote>亚马逊面临欧洲各地工人的黑色星期五罢工</blockquote>

2021-11-25

🤑

What Inflation? Small Investors Keep Piling Into Flashy Growth Stocks<blockquote>什么通货膨胀？小投资者不断涌入华丽的成长型股票</blockquote>

2021-11-24

🤑

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3565930395680990","uuid":"3565930395680990","gmtCreate":1602836610802,"gmtModify":1706620606114,"name":"TradeLegend","pinyin":"tradelegend","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":10,"headSize":7,"tweetSize":134,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.70%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.20%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":693599866,"gmtCreate":1640047130884,"gmtModify":1640047131033,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693599866","repostId":"1184187118","repostType":4,"isVote":1,"tweetType":1,"viewCount":2575,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693069194,"gmtCreate":1639930012033,"gmtModify":1639930012195,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/693069194","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=zh_CN&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&amp;P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&amp;A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块，涨幅约为2.5%，主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨，而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&amp;A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中，<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司，溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势，本周上涨约20.7%，有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗，股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时，这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后，该公司每周上涨约25.2%，使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时，Vir Biotechnology（纳斯达克股票代码：VIR）飙升约23.7%，成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克（纽约证券交易所股票代码：GSK）合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有，<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家：<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻，再次提高了COVID-19疫苗的销售指引，因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势，<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%，创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中，两家新IPO的生物技术公司Instil Bio（纳斯达克股票代码：TIL）和Exscientia（纳斯达克股票代码：EXAI）脱颖而出，尽管它们在华尔街获得了良好的评级，但分别下跌了19.3%和约13.5%。与此同时，处方药比价平台运营商GoodRx Holdings（纳斯达克股票代码：GDRX）股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的，<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>，暴跌约13.1%，受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics（纳斯达克股票代码：ALLO）在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋，其中包括Cathie Wood的Ark Investment Management，该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-19 11:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The healthcare stocks in the S&amp;P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&amp;A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块，涨幅约为2.5%，主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨，而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&amp;A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中，<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司，溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势，本周上涨约20.7%，有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗，股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时，这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后，该公司每周上涨约25.2%，使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时，Vir Biotechnology（纳斯达克股票代码：VIR）飙升约23.7%，成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克（纽约证券交易所股票代码：GSK）合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有，<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家：<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻，再次提高了COVID-19疫苗的销售指引，因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势，<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%，创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中，两家新IPO的生物技术公司Instil Bio（纳斯达克股票代码：TIL）和Exscientia（纳斯达克股票代码：EXAI）脱颖而出，尽管它们在华尔街获得了良好的评级，但分别下跌了19.3%和约13.5%。与此同时，处方药比价平台运营商GoodRx Holdings（纳斯达克股票代码：GDRX）股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的，<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>，暴跌约13.1%，受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics（纳斯达克股票代码：ALLO）在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋，其中包括Cathie Wood的Ark Investment Management，该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","ORCL":"甲骨文","PFE":"辉瑞","ARNA":"阿里那","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","CERN":"美国塞纳"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals  dominated with a ~83.8% rise after Pfizer  agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner  also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle  for the electronic-medical-records company.\nVaccine developer, Novavax  jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical  posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences  added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"PFE":0.9,"ORCL":0.9,"CERN":0.9,"ARNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699270807,"gmtCreate":1639824405751,"gmtModify":1639824405859,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699270807","repostId":"1189235922","repostType":4,"repost":{"id":"1189235922","kind":"news","pubTimestamp":1639809269,"share":"https://www.laohu8.com/m/news/1189235922?lang=zh_CN&edition=full","pubTime":"2021-12-18 14:34","market":"us","language":"en","title":"DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189235922","media":"Seeking Alpha","summary":"DaVita  Board of Directors increased the authorization under the existing share repurchase program b","content":"<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p><p><blockquote><a href=\"https://laohu8.com/S/DVA\">达维塔</a>董事会将现有股票回购计划下的授权增加了20亿美元的额外回购授权。</blockquote></p><p> The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p><p><blockquote>根据新授权授权回购的股份金额不包括2020年12月10日授权的公司现有股份回购计划下剩余的金额。</blockquote></p><p> Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p><p><blockquote>SA撰稿人对该股发表了一些看跌评论和评级，他写道：“该公司似乎被高估，该公司未来面临几项挑战。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-18 14:34</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p><p><blockquote><a href=\"https://laohu8.com/S/DVA\">达维塔</a>董事会将现有股票回购计划下的授权增加了20亿美元的额外回购授权。</blockquote></p><p> The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p><p><blockquote>根据新授权授权回购的股份金额不包括2020年12月10日授权的公司现有股份回购计划下剩余的金额。</blockquote></p><p> Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p><p><blockquote>SA撰稿人对该股发表了一些看跌评论和评级，他写道：“该公司似乎被高估，该公司未来面临几项挑战。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DVA":"达维塔保健"},"source_url":"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189235922","content_text":"DaVita  Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.\nThe amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .\nSome bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'","news_type":1,"symbols_score_info":{"DVA":0.9}},"isVote":1,"tweetType":1,"viewCount":2099,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690450573,"gmtCreate":1639703743619,"gmtModify":1639703743744,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690450573","repostId":"2192194909","repostType":4,"repost":{"id":"2192194909","kind":"highlight","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1639701314,"share":"https://www.laohu8.com/m/news/2192194909?lang=zh_CN&edition=full","pubTime":"2021-12-17 08:35","market":"us","language":"en","title":"Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain<blockquote>Adagio Therapeutics继续其狂野之旅——两项测试如何带来三位数的收益</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2192194909","media":"Investors","summary":"New analyses suggest Adagio Therapeutics' Covid antibody could still tackle the omicron variant — and ADGI stock soared on Thursday.","content":"<p>New analyses suggest <b><a href=\"https://laohu8.com/S/ADGI\">Adagio Therapeutics</a></b>' Covid antibody could still tackle the omicron variant — and ADGI stock soared on Thursday.</p><p><blockquote>新的分析表明<b><a href=\"https://laohu8.com/S/ADGI\">柔板疗法</a></b>“新冠抗体仍然可以应对奥密克戎病毒变种——ADGI股价周四飙升。</blockquote></p><p> Two studies from renowned laboratories in the U.S. and France suggest Adagio's experimental antibody-based drug, ADG20, fights omicron-induced Covid, Jefferies analyst Michael Yee wrote in a report to clients. In response, ADGI stock rocketed 106% near 13.10.</p><p><blockquote>杰富瑞(Jefferies)分析师Michael Yee在给客户的一份报告中写道，美国和法国知名实验室的两项研究表明，Adagio的实验性抗体药物ADG20可以对抗奥密克戎病毒引发的新冠病毒。作为回应，ADGI股价飙升106%，接近13.10。</blockquote></p><p> The news is a 180-degree turn from earlier this week when shares plummeted after Adagio said its antibody experienced a huge drop in effectiveness against omicron. Now, Yee says, it appears the Adagio drug is lining up with <b>Vir Biotechnology</b> and <b>GlaxoSmithKline</b>. Also this week, the duo said their antibody could effectively target omicron.</p><p><blockquote>这一消息与本周早些时候发生了180度的转变，当时Adagio表示其抗体对抗奥密克戎病的有效性大幅下降后，股价暴跌。Yee说，现在Adagio药物似乎正在与<b>维尔生物技术</b>和<b>葛兰素史克</b>同样在本周，两人表示，他们的抗体可以有效地靶向奥密克戎。</blockquote></p><p> \"So, maybe Adagio (drug ADG20) is not as bad as previously thought and is in the ballpark of GlaxoSmithKline/Vir which means it has utility and (effectiveness) and has a real role,\" Yee said.</p><p><blockquote>“因此，也许Adagio（药物ADG20）并不像之前想象的那么糟糕，并且处于葛兰素史克/Vir的大致范围内，这意味着它具有实用性和（有效性）并且具有真正的作用，”Yee说。</blockquote></p><p> <h2>ADGI Stock Continues Its Wild Ride</h2> Antibody drugs have taken a wild ride on the omicron train.</p><p><blockquote><h2>ADGI股票继续疯狂上涨</h2>抗体药物在奥密克戎列车上狂奔。</blockquote></p><p> Vaccines prompt the body to generate virus-blocking antibodies. Antibody-based treatments, on the other hand, simply infuse or inject a person with the virus blockers.</p><p><blockquote>疫苗促使身体产生阻断病毒的抗体。另一方面，基于抗体的治疗只是简单地给一个人输注或注射病毒阻断剂。</blockquote></p><p> But omicron contains numerous mutations to its spike protein, so antibodies find it harder to recognize. Adagio previously said none of omicron's mutations would hurt the effectiveness of its drug. But, on Tuesday, ADGI stock crashed after the company said that theory didn't pan out in further testing.</p><p><blockquote>但奥密克戎病毒的刺突蛋白包含许多突变，因此抗体发现它更难识别。Adagio此前表示，奥密克戎的任何突变都不会损害其药物的有效性。但是，周二，ADGI股价暴跌，此前该公司表示该理论在进一步测试中并未成功。</blockquote></p><p> \"We said this was a significant surprise because all data suggested their drug should be potent against omicron and even Adagio management said all along (that) all their prior work suggests the conserved binding region and other factors should lead it to be a great antibody against omicron and future variants,\" Yee said.</p><p><blockquote>“我们说这是一个巨大的惊喜，因为所有数据都表明他们的药物应该对奥密克戎病有效，甚至Adagio管理层也一直表示，他们之前的所有工作都表明保守结合区和其他因素应该使其成为一种很好的抗体。奥密克戎和未来的变种，”Yee说。</blockquote></p><p> The news on Thursday resulted in another flip for ADGI stock, however.</p><p><blockquote>然而，周四的消息导致ADGI股价再次上涨。</blockquote></p><p> The laboratories found omicron leads to a 20-40 times reduction in the effectiveness of ADG20 against omicron. That's better than the 300-fold drop Adagio estimated on Tuesday, Yee said. He has a 46 price target on ADGI stock.</p><p><blockquote>实验室发现，奥密克戎导致ADG20对抗奥密克戎的有效性降低20-40倍。Yee说，这比Adagio周二估计的300倍下降要好。他对ADGI股票的目标价为46美元。</blockquote></p><p> <h2>Other Antibodies Target Omicron</h2> Similarly, on Thursday, <b>AstraZeneca</b> said its antibody is less effective against omicron than it is against the original strain. But that drug, dubbed Evusheld, can still target omicron, AstraZeneca said.</p><p><blockquote><h2>其他抗体靶向奥密克戎</h2>同样，周四，<b>阿斯利康</b>称其抗体对抗奥密克戎病毒的效果不如对抗原始毒株。但阿斯利康表示，这种名为Evusheld的药物仍然可以针对奥密克戎病。</blockquote></p><p> AstraZeneca stock rose 1.87% near 56.70 in midday trading on the stock market today. Vir stock continued a six-day running spree, jumping 8.5% near 56. On Wednesday, Vir stock broke out of a cup-with-handle base with a buy point at 52.95, according to MarketSmith.com.</p><p><blockquote>今天股市午盘交易中，阿斯利康股价上涨1.87%，接近56.70点。Vir股价继续连续六天上涨，上涨8.5%，接近56点。根据MarketSmith.com的数据，周三，Vir股票突破了带手柄的杯子底部，买入点为52.95。</blockquote></p><p> Meanwhile, <b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> stock crept down 3.5% near 635. The company said its currently authorized antibody regimen loses effectiveness against omicron. But, Regeneron said, its next-generation antibodies can target omicron and delta. Those antibodies don't have authorization, however.</p><p><blockquote>同时，<b><a href=\"https://laohu8.com/S/REGN\">再生元制药</a></b>股价在635点附近下跌3.5%。该公司表示，其目前授权的抗体方案对奥密克戎病毒失去了效力。但是，再生元表示，其下一代抗体可以针对奥密克戎和德尔塔。然而，这些抗体没有授权。</blockquote></p><p> It's important to note that ADGI stock is lowly rated across IBD Digital measures. Shares have a rock-bottom Relative Strength Rating of 1, putting its 12-month performance in the bottom 1% of all stocks.</p><p><blockquote>值得注意的是，ADGI股票在IBD Digital指标中的评级较低。该股的相对强度评级为1，处于最低水平，其12个月表现在所有股票中排名垫底1%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain<blockquote>Adagio Therapeutics继续其狂野之旅——两项测试如何带来三位数的收益</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdagio Therapeutics Continues Its Wild Ride — How Two Tests Led To A Triple-Digit Gain<blockquote>Adagio Therapeutics继续其狂野之旅——两项测试如何带来三位数的收益</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time smaller\">2021-12-17 08:35</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p>New analyses suggest <b><a href=\"https://laohu8.com/S/ADGI\">Adagio Therapeutics</a></b>' Covid antibody could still tackle the omicron variant — and ADGI stock soared on Thursday.</p><p><blockquote>新的分析表明<b><a href=\"https://laohu8.com/S/ADGI\">柔板疗法</a></b>“新冠抗体仍然可以应对奥密克戎病毒变种——ADGI股价周四飙升。</blockquote></p><p> Two studies from renowned laboratories in the U.S. and France suggest Adagio's experimental antibody-based drug, ADG20, fights omicron-induced Covid, Jefferies analyst Michael Yee wrote in a report to clients. In response, ADGI stock rocketed 106% near 13.10.</p><p><blockquote>杰富瑞(Jefferies)分析师Michael Yee在给客户的一份报告中写道，美国和法国知名实验室的两项研究表明，Adagio的实验性抗体药物ADG20可以对抗奥密克戎病毒引发的新冠病毒。作为回应，ADGI股价飙升106%，接近13.10。</blockquote></p><p> The news is a 180-degree turn from earlier this week when shares plummeted after Adagio said its antibody experienced a huge drop in effectiveness against omicron. Now, Yee says, it appears the Adagio drug is lining up with <b>Vir Biotechnology</b> and <b>GlaxoSmithKline</b>. Also this week, the duo said their antibody could effectively target omicron.</p><p><blockquote>这一消息与本周早些时候发生了180度的转变，当时Adagio表示其抗体对抗奥密克戎病的有效性大幅下降后，股价暴跌。Yee说，现在Adagio药物似乎正在与<b>维尔生物技术</b>和<b>葛兰素史克</b>同样在本周，两人表示，他们的抗体可以有效地靶向奥密克戎。</blockquote></p><p> \"So, maybe Adagio (drug ADG20) is not as bad as previously thought and is in the ballpark of GlaxoSmithKline/Vir which means it has utility and (effectiveness) and has a real role,\" Yee said.</p><p><blockquote>“因此，也许Adagio（药物ADG20）并不像之前想象的那么糟糕，并且处于葛兰素史克/Vir的大致范围内，这意味着它具有实用性和（有效性）并且具有真正的作用，”Yee说。</blockquote></p><p> <h2>ADGI Stock Continues Its Wild Ride</h2> Antibody drugs have taken a wild ride on the omicron train.</p><p><blockquote><h2>ADGI股票继续疯狂上涨</h2>抗体药物在奥密克戎列车上狂奔。</blockquote></p><p> Vaccines prompt the body to generate virus-blocking antibodies. Antibody-based treatments, on the other hand, simply infuse or inject a person with the virus blockers.</p><p><blockquote>疫苗促使身体产生阻断病毒的抗体。另一方面，基于抗体的治疗只是简单地给一个人输注或注射病毒阻断剂。</blockquote></p><p> But omicron contains numerous mutations to its spike protein, so antibodies find it harder to recognize. Adagio previously said none of omicron's mutations would hurt the effectiveness of its drug. But, on Tuesday, ADGI stock crashed after the company said that theory didn't pan out in further testing.</p><p><blockquote>但奥密克戎病毒的刺突蛋白包含许多突变，因此抗体发现它更难识别。Adagio此前表示，奥密克戎的任何突变都不会损害其药物的有效性。但是，周二，ADGI股价暴跌，此前该公司表示该理论在进一步测试中并未成功。</blockquote></p><p> \"We said this was a significant surprise because all data suggested their drug should be potent against omicron and even Adagio management said all along (that) all their prior work suggests the conserved binding region and other factors should lead it to be a great antibody against omicron and future variants,\" Yee said.</p><p><blockquote>“我们说这是一个巨大的惊喜，因为所有数据都表明他们的药物应该对奥密克戎病有效，甚至Adagio管理层也一直表示，他们之前的所有工作都表明保守结合区和其他因素应该使其成为一种很好的抗体。奥密克戎和未来的变种，”Yee说。</blockquote></p><p> The news on Thursday resulted in another flip for ADGI stock, however.</p><p><blockquote>然而，周四的消息导致ADGI股价再次上涨。</blockquote></p><p> The laboratories found omicron leads to a 20-40 times reduction in the effectiveness of ADG20 against omicron. That's better than the 300-fold drop Adagio estimated on Tuesday, Yee said. He has a 46 price target on ADGI stock.</p><p><blockquote>实验室发现，奥密克戎导致ADG20对抗奥密克戎的有效性降低20-40倍。Yee说，这比Adagio周二估计的300倍下降要好。他对ADGI股票的目标价为46美元。</blockquote></p><p> <h2>Other Antibodies Target Omicron</h2> Similarly, on Thursday, <b>AstraZeneca</b> said its antibody is less effective against omicron than it is against the original strain. But that drug, dubbed Evusheld, can still target omicron, AstraZeneca said.</p><p><blockquote><h2>其他抗体靶向奥密克戎</h2>同样，周四，<b>阿斯利康</b>称其抗体对抗奥密克戎病毒的效果不如对抗原始毒株。但阿斯利康表示，这种名为Evusheld的药物仍然可以针对奥密克戎病。</blockquote></p><p> AstraZeneca stock rose 1.87% near 56.70 in midday trading on the stock market today. Vir stock continued a six-day running spree, jumping 8.5% near 56. On Wednesday, Vir stock broke out of a cup-with-handle base with a buy point at 52.95, according to MarketSmith.com.</p><p><blockquote>今天股市午盘交易中，阿斯利康股价上涨1.87%，接近56.70点。Vir股价继续连续六天上涨，上涨8.5%，接近56点。根据MarketSmith.com的数据，周三，Vir股票突破了带手柄的杯子底部，买入点为52.95。</blockquote></p><p> Meanwhile, <b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> stock crept down 3.5% near 635. The company said its currently authorized antibody regimen loses effectiveness against omicron. But, Regeneron said, its next-generation antibodies can target omicron and delta. Those antibodies don't have authorization, however.</p><p><blockquote>同时，<b><a href=\"https://laohu8.com/S/REGN\">再生元制药</a></b>股价在635点附近下跌3.5%。该公司表示，其目前授权的抗体方案对奥密克戎病毒失去了效力。但是，再生元表示，其下一代抗体可以针对奥密克戎和德尔塔。然而，这些抗体没有授权。</blockquote></p><p> It's important to note that ADGI stock is lowly rated across IBD Digital measures. Shares have a rock-bottom Relative Strength Rating of 1, putting its 12-month performance in the bottom 1% of all stocks.</p><p><blockquote>值得注意的是，ADGI股票在IBD Digital指标中的评级较低。该股的相对强度评级为1，处于最低水平，其12个月表现在所有股票中排名垫底1%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4539":"次新股","BK4139":"生物科技"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192194909","content_text":"New analyses suggest Adagio Therapeutics' Covid antibody could still tackle the omicron variant — and ADGI stock soared on Thursday.\nTwo studies from renowned laboratories in the U.S. and France suggest Adagio's experimental antibody-based drug, ADG20, fights omicron-induced Covid, Jefferies analyst Michael Yee wrote in a report to clients. In response, ADGI stock rocketed 106% near 13.10.\nThe news is a 180-degree turn from earlier this week when shares plummeted after Adagio said its antibody experienced a huge drop in effectiveness against omicron. Now, Yee says, it appears the Adagio drug is lining up with Vir Biotechnology and GlaxoSmithKline. Also this week, the duo said their antibody could effectively target omicron.\n\"So, maybe Adagio (drug ADG20) is not as bad as previously thought and is in the ballpark of GlaxoSmithKline/Vir which means it has utility and (effectiveness) and has a real role,\" Yee said.\nADGI Stock Continues Its Wild Ride\nAntibody drugs have taken a wild ride on the omicron train.\nVaccines prompt the body to generate virus-blocking antibodies. Antibody-based treatments, on the other hand, simply infuse or inject a person with the virus blockers.\nBut omicron contains numerous mutations to its spike protein, so antibodies find it harder to recognize. Adagio previously said none of omicron's mutations would hurt the effectiveness of its drug. But, on Tuesday, ADGI stock crashed after the company said that theory didn't pan out in further testing.\n\"We said this was a significant surprise because all data suggested their drug should be potent against omicron and even Adagio management said all along (that) all their prior work suggests the conserved binding region and other factors should lead it to be a great antibody against omicron and future variants,\" Yee said.\nThe news on Thursday resulted in another flip for ADGI stock, however.\nThe laboratories found omicron leads to a 20-40 times reduction in the effectiveness of ADG20 against omicron. That's better than the 300-fold drop Adagio estimated on Tuesday, Yee said. He has a 46 price target on ADGI stock.\nOther Antibodies Target Omicron\nSimilarly, on Thursday, AstraZeneca said its antibody is less effective against omicron than it is against the original strain. But that drug, dubbed Evusheld, can still target omicron, AstraZeneca said.\nAstraZeneca stock rose 1.87% near 56.70 in midday trading on the stock market today. Vir stock continued a six-day running spree, jumping 8.5% near 56. On Wednesday, Vir stock broke out of a cup-with-handle base with a buy point at 52.95, according to MarketSmith.com.\nMeanwhile, Regeneron Pharmaceuticals stock crept down 3.5% near 635. The company said its currently authorized antibody regimen loses effectiveness against omicron. But, Regeneron said, its next-generation antibodies can target omicron and delta. Those antibodies don't have authorization, however.\nIt's important to note that ADGI stock is lowly rated across IBD Digital measures. Shares have a rock-bottom Relative Strength Rating of 1, putting its 12-month performance in the bottom 1% of all stocks.","news_type":1,"symbols_score_info":{"ADGI":0.9}},"isVote":1,"tweetType":1,"viewCount":2486,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690059971,"gmtCreate":1639615627130,"gmtModify":1639615627236,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690059971","repostId":"1172070133","repostType":4,"repost":{"id":"1172070133","kind":"news","pubTimestamp":1639621250,"share":"https://www.laohu8.com/m/news/1172070133?lang=zh_CN&edition=full","pubTime":"2021-12-16 10:20","market":"us","language":"en","title":"All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172070133","media":"MarketWatch","summary":"The U.S. central bank charts a completely new course to attack inflation rather than continue to wai","content":"<p>The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out</p><p><blockquote>美联储制定了一条全新的路线来打击通胀，而不是继续等待通胀结束</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ba1b24817095f66e1cbf69b3dd7a4ad8\" tg-width=\"700\" tg-height=\"399\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy&nbsp;or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.</p><p><blockquote>美联储周三会议的重大消息并不是它将停止购买债券来刺激经济，也不是它现在暗示将在2022年三次上调基准贷款利率。过去一个月，美联储官员已经充分传达了这些短期政策决定。</blockquote></p><p> No, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.</p><p><blockquote>不，最令人惊讶的是，庞大的、厌恶变革的美联储对通胀的看法发生了180度的转变。</blockquote></p><p> The Fed’s statement&nbsp;Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.</p><p><blockquote>美联储周三的声明和附带的材料表明，鸽派——普遍认为通胀风险被夸大的政策制定者——已经完全投降。现在每个人都是鹰。美联储已经没有鸽派了。</blockquote></p><p> Fed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.</p><p><blockquote>美联储货币政策制定者一致认为，对抗通胀是他们的首要任务。他们可能在策略或时机上存在分歧，但在尽快战胜通胀的策略上却没有分歧。美联储处于战争状态，通胀是敌人。</blockquote></p><p> For 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.</p><p><blockquote>30年来，鸽派一直是对的：通货膨胀不是经济的最大威胁；失业是。鸽派打了一场最终成功的战斗，迫使美联储考虑失业给社会和经济留下的许多个人带来的非常真实的成本。</blockquote></p><p> But now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.</p><p><blockquote>但现在，冠状病毒大流行的影响甚至迫使鸽派接受通胀是比失业更大的威胁。对于一个不喜欢变化的机构来说，这是一个巨大的变化。</blockquote></p><p> How do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.</p><p><blockquote>我们怎么知道鸽子已经变成鹰了？看看点阵图，这是美联储每三个月发布一次的图表，显示了每个货币政策制定者对未来几年底联邦基金利率水平的匿名个人预测。</blockquote></p><p> Most analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.</p><p><blockquote>大多数分析师正确地关注来年的预测中值，但我想将您的注意力简要地转移到异常值（美联储最鹰派和鸽派成员）的中期预测上，以显示战场有多大自11月10日可怕的消费者价格指数数据以来，美联储内部发生了变化。那份报告改变了美联储的一切。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fc738ce106c9173e3b5b93bf435f87f7\" tg-width=\"700\" tg-height=\"644\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> In the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.</p><p><blockquote>在周三发布的最新预测中，最鹰派的成员将2023年底的中期预测从1.63%温和上调至2.13%，2024年底从2.63%上调至3.13%。五位最鹰派的成员现在认为，美联储将不得不将联邦基金利率推高至2.5%的假设长期均衡水平之上。</blockquote></p><p> But the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.</p><p><blockquote>但是鸽派彻底撕毁了他们之前的预测。五位最鸽派的成员此前预测，到2023年底，加息幅度将在零到两次之间，但现在他们预计加息四到五次。到2024年底，他们一直预测加息两到四次；现在他们预计是七个。</blockquote></p><p> Clearly, even the most dovish Fed officials now believe&nbsp;the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.</p><p><blockquote>显然，即使是最鸽派的美联储官员现在也认为，联邦基金利率必须大幅上升才能战胜通胀。以前，他们认为通货膨胀会自行下降。</blockquote></p><p> This means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.</p><p><blockquote>这意味着通货膨胀不再受益。它被证明是有罪的，即使是鸽派也会继续战争，直到取得胜利。对于美联储通胀鸽派来说，2021年11月10日有点像1941年12月7日：是时候开战了。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAll the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-12-16 10:20</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out</p><p><blockquote>美联储制定了一条全新的路线来打击通胀，而不是继续等待通胀结束</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ba1b24817095f66e1cbf69b3dd7a4ad8\" tg-width=\"700\" tg-height=\"399\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy&nbsp;or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.</p><p><blockquote>美联储周三会议的重大消息并不是它将停止购买债券来刺激经济，也不是它现在暗示将在2022年三次上调基准贷款利率。过去一个月，美联储官员已经充分传达了这些短期政策决定。</blockquote></p><p> No, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.</p><p><blockquote>不，最令人惊讶的是，庞大的、厌恶变革的美联储对通胀的看法发生了180度的转变。</blockquote></p><p> The Fed’s statement&nbsp;Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.</p><p><blockquote>美联储周三的声明和附带的材料表明，鸽派——普遍认为通胀风险被夸大的政策制定者——已经完全投降。现在每个人都是鹰。美联储已经没有鸽派了。</blockquote></p><p> Fed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.</p><p><blockquote>美联储货币政策制定者一致认为，对抗通胀是他们的首要任务。他们可能在策略或时机上存在分歧，但在尽快战胜通胀的策略上却没有分歧。美联储处于战争状态，通胀是敌人。</blockquote></p><p> For 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.</p><p><blockquote>30年来，鸽派一直是对的：通货膨胀不是经济的最大威胁；失业是。鸽派打了一场最终成功的战斗，迫使美联储考虑失业给社会和经济留下的许多个人带来的非常真实的成本。</blockquote></p><p> But now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.</p><p><blockquote>但现在，冠状病毒大流行的影响甚至迫使鸽派接受通胀是比失业更大的威胁。对于一个不喜欢变化的机构来说，这是一个巨大的变化。</blockquote></p><p> How do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.</p><p><blockquote>我们怎么知道鸽子已经变成鹰了？看看点阵图，这是美联储每三个月发布一次的图表，显示了每个货币政策制定者对未来几年底联邦基金利率水平的匿名个人预测。</blockquote></p><p> Most analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.</p><p><blockquote>大多数分析师正确地关注来年的预测中值，但我想将您的注意力简要地转移到异常值（美联储最鹰派和鸽派成员）的中期预测上，以显示战场有多大自11月10日可怕的消费者价格指数数据以来，美联储内部发生了变化。那份报告改变了美联储的一切。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fc738ce106c9173e3b5b93bf435f87f7\" tg-width=\"700\" tg-height=\"644\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> In the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.</p><p><blockquote>在周三发布的最新预测中，最鹰派的成员将2023年底的中期预测从1.63%温和上调至2.13%，2024年底从2.63%上调至3.13%。五位最鹰派的成员现在认为，美联储将不得不将联邦基金利率推高至2.5%的假设长期均衡水平之上。</blockquote></p><p> But the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.</p><p><blockquote>但是鸽派彻底撕毁了他们之前的预测。五位最鸽派的成员此前预测，到2023年底，加息幅度将在零到两次之间，但现在他们预计加息四到五次。到2024年底，他们一直预测加息两到四次；现在他们预计是七个。</blockquote></p><p> Clearly, even the most dovish Fed officials now believe&nbsp;the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.</p><p><blockquote>显然，即使是最鸽派的美联储官员现在也认为，联邦基金利率必须大幅上升才能战胜通胀。以前，他们认为通货膨胀会自行下降。</blockquote></p><p> This means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.</p><p><blockquote>这意味着通货膨胀不再受益。它被证明是有罪的，即使是鸽派也会继续战争，直到取得胜利。对于美联储通胀鸽派来说，2021年11月10日有点像1941年12月7日：是时候开战了。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/all-the-doves-at-the-fed-have-become-hawks-11639613760?mod=mw_latestnews\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/all-the-doves-at-the-fed-have-become-hawks-11639613760?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172070133","content_text":"The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out\n\nThe big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.\nNo, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.\nThe Fed’s statement Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.\nFed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.\nFor 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.\nBut now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.\nHow do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.\nMost analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.\n\nIn the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.\nBut the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.\nClearly, even the most dovish Fed officials now believe the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.\nThis means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3038,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607695836,"gmtCreate":1639530829485,"gmtModify":1639530829588,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607695836","repostId":"1129773083","repostType":4,"isVote":1,"tweetType":1,"viewCount":3009,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604472686,"gmtCreate":1639442680885,"gmtModify":1639442680992,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604472686","repostId":"2191811539","repostType":4,"isVote":1,"tweetType":1,"viewCount":2417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604675566,"gmtCreate":1639395534696,"gmtModify":1639395534808,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604675566","repostId":"1131710846","repostType":4,"repost":{"id":"1131710846","kind":"news","pubTimestamp":1639393441,"share":"https://www.laohu8.com/m/news/1131710846?lang=zh_CN&edition=full","pubTime":"2021-12-13 19:04","market":"us","language":"en","title":"Stock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1131710846","media":"WSJ","summary":"U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank dec","content":"<p>U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p><p><blockquote>美国股指期货显示，在主要经济体央行决策繁忙的一周之前，主要股指涨幅温和。</blockquote></p><p> Futures for the S&amp;P 500 rose 0.2% Monday, after the benchmark gauge closed last week at its67th record high of 2021. Contracts for the Dow Jones Industrial Average, which sits just shy of an all-time high, also ticked up 0.2%, as did futures for the technology-heavy Nasdaq-100.</p><p><blockquote>标普500期货周一上涨0.2%，此前该基准指数上周收于2021年第67次历史新高。接近历史高点的道琼斯工业平均指数合约也上涨0.2%，以科技股为主的纳斯达克100指数期货也上涨0.2%。</blockquote></p><p> In the bond market, the yield on benchmark 10-year Treasury notes ticked up to 1.492% Monday from 1.487% Friday. Yields move in the opposite direction to bond prices.</p><p><blockquote>在债券市场，基准10年期国债收益率从周五的1.487%升至周一的1.492%。收益率的变动方向与债券价格相反。</blockquote></p><p> Investors are sitting tight ahead of a monetary-policy decision by the Federal Reserve and announcements from the Bank of England, European Central Bank and&nbsp;Bank of Japan&nbsp;later in the week. The Fed is expected to accelerate the pace at which it is paring its bond-buying program and to signal that it will raise interest rates next year to tap the brakes on inflation. Data published Friday showed consumer prices increased in November at the&nbsp;fastest annual rate since 1982.</p><p><blockquote>投资者对美联储的货币政策决定以及英国央行、欧洲央行和日本央行本周晚些时候的公告持观望态度。预计美联储将加快削减债券购买计划的步伐，并暗示明年将加息以抑制通胀。周五公布的数据显示，11月份消费者价格以1982年以来最快的年增长率上涨。</blockquote></p><p> Gregory Perdon, co-chief investment officer at&nbsp;Arbuthnot Latham,said he expects stocks to keep rising even as the Fed tightens monetary policy.</p><p><blockquote>Arbuthnot Latham联席首席投资官Gregory Perdon表示，即使美联储收紧货币政策，他预计股市仍将继续上涨。</blockquote></p><p> “The classic textbook would be rates up, stocks down,” Mr. Perdon said. “The reality is there’s so much liquidity out there, there’s so much demand to get a return on assets that ultimately we’re going to have to have a much…more aggressive tightening to knock stocks.”</p><p><blockquote>“经典的教科书是利率上升，股票下跌，”珀登先生说。“现实情况是，流动性如此之多，获得资产回报的需求如此之大，最终我们将不得不采取……更激进的紧缩措施来打击股市。”</blockquote></p><p> Commodity prices rose. Brent-crude futures, the benchmark in international energy markets, ticked up 0.5% to $75.53 a barrel. Prices snapped a six-week losing streak Friday, recovering some ground shed when the Omicron variant threatened to hit oil demand.</p><p><blockquote>大宗商品价格上涨。国际能源市场基准布伦特原油期货上涨0.5%，至每桶75.53美元。周五，油价结束了连续六周的下跌，收复了奥密克戎变种威胁打击石油需求时的一些下跌。</blockquote></p><p> European natural-gas prices jumped more than 8% Monday. Supplies of gas, a key heating and power-generation fuel in Europe, are well below their recent average for the time of year, raising concerns stockpiles will run low as cold weather lifts demand. U.S. natural-gas futures rose 1.9% to $4 per million British thermal units.</p><p><blockquote>欧洲天然气价格周一上涨超过8%。天然气是欧洲主要的供暖和发电燃料，其供应量远低于最近一年同期的平均水平，这引发了人们的担忧，即随着寒冷天气提振需求，库存将会减少。美国天然气期货上涨1.9%，至每百万英热单位4美元。</blockquote></p><p> Turkey’s lira slumped 4% to trade at 14.46 to the dollar ahead of an expected rate cut by the central bank on Thursday. The Central Bank of the Republic of Turkey has bowed to pressure from President Recep Tayyip Erdogan to lower borrowing costs this year in the face of rapid inflation, hitting the currency hard.</p><p><blockquote>在央行周四预期降息之前，土耳其里拉兑美元汇率下跌4%，至14.46里拉。面对快速通胀，土耳其共和国中央银行屈服于总统雷杰普·塔伊普·埃尔多安今年降低借贷成本的压力，对货币造成了沉重打击。</blockquote></p><p> Overseas stock markets were mixed. The Stoxx Europe 600 edged up 0.1%, led higher by shares of basic-resources, auto and oil-and-gas companies. Among individual movers,Vifor Pharmajumped more than 15% after the Swiss pharmaceutical firm said it was in talks to be bought by Australia’s CSL.</p><p><blockquote>海外股市涨跌互现。斯托克欧洲600指数小幅上涨0.1%，基础资源、汽车和石油天然气公司的股价领涨。在个别推动者中，瑞士制药公司Vifor Pharma表示正在就被澳大利亚CSL收购进行谈判后，该公司股价上涨超过15%。</blockquote></p><p> Japan’s Nikkei 225 rose 0.7%, the Shanghai Composite Index added 0.4% and Hong Kong’s Hang Seng slipped 0.2%.</p><p><blockquote>日本日经225指数上涨0.7%，上证综合指数上涨0.4%，香港恒生指数下跌0.2%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Futures Edge Up After S&P 500 Hits Record<blockquote>标普500创历史新高后股指期货小幅上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">WSJ</strong><span class=\"h-time small\">2021-12-13 19:04</span>\n</p>\n</h4>\n</header>\n<article>\n<p>U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.</p><p><blockquote>美国股指期货显示，在主要经济体央行决策繁忙的一周之前，主要股指涨幅温和。</blockquote></p><p> Futures for the S&amp;P 500 rose 0.2% Monday, after the benchmark gauge closed last week at its67th record high of 2021. Contracts for the Dow Jones Industrial Average, which sits just shy of an all-time high, also ticked up 0.2%, as did futures for the technology-heavy Nasdaq-100.</p><p><blockquote>标普500期货周一上涨0.2%，此前该基准指数上周收于2021年第67次历史新高。接近历史高点的道琼斯工业平均指数合约也上涨0.2%，以科技股为主的纳斯达克100指数期货也上涨0.2%。</blockquote></p><p> In the bond market, the yield on benchmark 10-year Treasury notes ticked up to 1.492% Monday from 1.487% Friday. Yields move in the opposite direction to bond prices.</p><p><blockquote>在债券市场，基准10年期国债收益率从周五的1.487%升至周一的1.492%。收益率的变动方向与债券价格相反。</blockquote></p><p> Investors are sitting tight ahead of a monetary-policy decision by the Federal Reserve and announcements from the Bank of England, European Central Bank and&nbsp;Bank of Japan&nbsp;later in the week. The Fed is expected to accelerate the pace at which it is paring its bond-buying program and to signal that it will raise interest rates next year to tap the brakes on inflation. Data published Friday showed consumer prices increased in November at the&nbsp;fastest annual rate since 1982.</p><p><blockquote>投资者对美联储的货币政策决定以及英国央行、欧洲央行和日本央行本周晚些时候的公告持观望态度。预计美联储将加快削减债券购买计划的步伐，并暗示明年将加息以抑制通胀。周五公布的数据显示，11月份消费者价格以1982年以来最快的年增长率上涨。</blockquote></p><p> Gregory Perdon, co-chief investment officer at&nbsp;Arbuthnot Latham,said he expects stocks to keep rising even as the Fed tightens monetary policy.</p><p><blockquote>Arbuthnot Latham联席首席投资官Gregory Perdon表示，即使美联储收紧货币政策，他预计股市仍将继续上涨。</blockquote></p><p> “The classic textbook would be rates up, stocks down,” Mr. Perdon said. “The reality is there’s so much liquidity out there, there’s so much demand to get a return on assets that ultimately we’re going to have to have a much…more aggressive tightening to knock stocks.”</p><p><blockquote>“经典的教科书是利率上升，股票下跌，”珀登先生说。“现实情况是，流动性如此之多，获得资产回报的需求如此之大，最终我们将不得不采取……更激进的紧缩措施来打击股市。”</blockquote></p><p> Commodity prices rose. Brent-crude futures, the benchmark in international energy markets, ticked up 0.5% to $75.53 a barrel. Prices snapped a six-week losing streak Friday, recovering some ground shed when the Omicron variant threatened to hit oil demand.</p><p><blockquote>大宗商品价格上涨。国际能源市场基准布伦特原油期货上涨0.5%，至每桶75.53美元。周五，油价结束了连续六周的下跌，收复了奥密克戎变种威胁打击石油需求时的一些下跌。</blockquote></p><p> European natural-gas prices jumped more than 8% Monday. Supplies of gas, a key heating and power-generation fuel in Europe, are well below their recent average for the time of year, raising concerns stockpiles will run low as cold weather lifts demand. U.S. natural-gas futures rose 1.9% to $4 per million British thermal units.</p><p><blockquote>欧洲天然气价格周一上涨超过8%。天然气是欧洲主要的供暖和发电燃料，其供应量远低于最近一年同期的平均水平，这引发了人们的担忧，即随着寒冷天气提振需求，库存将会减少。美国天然气期货上涨1.9%，至每百万英热单位4美元。</blockquote></p><p> Turkey’s lira slumped 4% to trade at 14.46 to the dollar ahead of an expected rate cut by the central bank on Thursday. The Central Bank of the Republic of Turkey has bowed to pressure from President Recep Tayyip Erdogan to lower borrowing costs this year in the face of rapid inflation, hitting the currency hard.</p><p><blockquote>在央行周四预期降息之前，土耳其里拉兑美元汇率下跌4%，至14.46里拉。面对快速通胀，土耳其共和国中央银行屈服于总统雷杰普·塔伊普·埃尔多安今年降低借贷成本的压力，对货币造成了沉重打击。</blockquote></p><p> Overseas stock markets were mixed. The Stoxx Europe 600 edged up 0.1%, led higher by shares of basic-resources, auto and oil-and-gas companies. Among individual movers,Vifor Pharmajumped more than 15% after the Swiss pharmaceutical firm said it was in talks to be bought by Australia’s CSL.</p><p><blockquote>海外股市涨跌互现。斯托克欧洲600指数小幅上涨0.1%，基础资源、汽车和石油天然气公司的股价领涨。在个别推动者中，瑞士制药公司Vifor Pharma表示正在就被澳大利亚CSL收购进行谈判后，该公司股价上涨超过15%。</blockquote></p><p> Japan’s Nikkei 225 rose 0.7%, the Shanghai Composite Index added 0.4% and Hong Kong’s Hang Seng slipped 0.2%.</p><p><blockquote>日本日经225指数上涨0.7%，上证综合指数上涨0.4%，香港恒生指数下跌0.2%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-13-2021-11639384564?mod=hp_lead_pos1\">WSJ</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-13-2021-11639384564?mod=hp_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131710846","content_text":"U.S. stock futures pointed to muted gains for major indexes ahead of a busy week of central-bank decisions in major economies.\nFutures for the S&P 500 rose 0.2% Monday, after the benchmark gauge closed last week at its67th record high of 2021. Contracts for the Dow Jones Industrial Average, which sits just shy of an all-time high, also ticked up 0.2%, as did futures for the technology-heavy Nasdaq-100.\nIn the bond market, the yield on benchmark 10-year Treasury notes ticked up to 1.492% Monday from 1.487% Friday. Yields move in the opposite direction to bond prices.\nInvestors are sitting tight ahead of a monetary-policy decision by the Federal Reserve and announcements from the Bank of England, European Central Bank and Bank of Japan later in the week. The Fed is expected to accelerate the pace at which it is paring its bond-buying program and to signal that it will raise interest rates next year to tap the brakes on inflation. Data published Friday showed consumer prices increased in November at the fastest annual rate since 1982.\nGregory Perdon, co-chief investment officer at Arbuthnot Latham,said he expects stocks to keep rising even as the Fed tightens monetary policy.\n“The classic textbook would be rates up, stocks down,” Mr. Perdon said. “The reality is there’s so much liquidity out there, there’s so much demand to get a return on assets that ultimately we’re going to have to have a much…more aggressive tightening to knock stocks.”\nCommodity prices rose. Brent-crude futures, the benchmark in international energy markets, ticked up 0.5% to $75.53 a barrel. Prices snapped a six-week losing streak Friday, recovering some ground shed when the Omicron variant threatened to hit oil demand.\nEuropean natural-gas prices jumped more than 8% Monday. Supplies of gas, a key heating and power-generation fuel in Europe, are well below their recent average for the time of year, raising concerns stockpiles will run low as cold weather lifts demand. U.S. natural-gas futures rose 1.9% to $4 per million British thermal units.\nTurkey’s lira slumped 4% to trade at 14.46 to the dollar ahead of an expected rate cut by the central bank on Thursday. The Central Bank of the Republic of Turkey has bowed to pressure from President Recep Tayyip Erdogan to lower borrowing costs this year in the face of rapid inflation, hitting the currency hard.\nOverseas stock markets were mixed. The Stoxx Europe 600 edged up 0.1%, led higher by shares of basic-resources, auto and oil-and-gas companies. Among individual movers,Vifor Pharmajumped more than 15% after the Swiss pharmaceutical firm said it was in talks to be bought by Australia’s CSL.\nJapan’s Nikkei 225 rose 0.7%, the Shanghai Composite Index added 0.4% and Hong Kong’s Hang Seng slipped 0.2%.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,"BZmain":0.9,"YMmain":0.9,"CLmain":0.9,".IXIC":0.9,"NQmain":0.9,"ESmain":0.9}},"isVote":1,"tweetType":1,"viewCount":3290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604301439,"gmtCreate":1639325093032,"gmtModify":1639325093141,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/604301439","repostId":"2190719536","repostType":4,"isVote":1,"tweetType":1,"viewCount":2685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605624338,"gmtCreate":1639155725026,"gmtModify":1639155782282,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605624338","repostId":"1165282830","repostType":4,"repost":{"id":"1165282830","kind":"news","pubTimestamp":1639148461,"share":"https://www.laohu8.com/m/news/1165282830?lang=zh_CN&edition=full","pubTime":"2021-12-10 23:01","market":"us","language":"en","title":"Tesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1165282830","media":"Electrek","summary":"Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outs","content":"<p>Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outside North America.</p><p><blockquote>特斯拉今天向潜在买家宣布，停止接受北美以外的新Model S和Model X订单。</blockquote></p><p> It now expects deliveries in other markets to start during the second half of 2022.</p><p><blockquote>目前预计其他市场的交付将于2022年下半年开始。</blockquote></p><p> The news comes from an email that Tesla started sending out to people who have Model S and Model X vehicles on order in Europe.</p><p><blockquote>该消息来自特斯拉开始向在欧洲订购Model S和Model X车辆的人发送的一封电子邮件。</blockquote></p><p> Tesla writes in the email that it is not accepting any new orders (translated from German):</p><p><blockquote>特斯拉在电子邮件中写道，它不接受任何新订单（翻译自德语）：</blockquote></p><p>   In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America.  This is in response to Tesla likely having a large backlog of Model S/X orders in Europe and other markets, where there has been no new Model S/X shipment in a year.</p><p><blockquote>为了尽可能加快现有订单（包括您的Model X订单）的交付，我们目前不再接受来自北美以外市场的Model S和Model X的新订单。这是为了应对特斯拉可能在欧洲和其他市场积压了大量Model S/X订单，这些市场已经一年没有新的Model S/X出货。</blockquote></p><p> Tesla shut down Model S and Model X production in January of last year to update the vehicles.</p><p><blockquote>特斯拉于去年1月关闭了Model S和Model X的生产以更新车辆。</blockquote></p><p> During that year, the automaker kept taking new orders, but production was delayed with new Model S starting to slowly come off the assembly line in June and&nbsp;Model X in October.</p><p><blockquote>那一年，该汽车制造商不断接受新订单，但生产被推迟，新款Model S于6月开始慢慢下线，Model X于10月开始下线。</blockquote></p><p> Tesla is still catching up to the backlog in North America while new orders kept coming in from Europe and Asia.</p><p><blockquote>特斯拉仍在追赶北美的积压订单，而新订单不断来自欧洲和亚洲。</blockquote></p><p> In the email, Tesla says that it now aims to deliver the first Model S and Model X in Europe during the second half of next year:</p><p><blockquote>特斯拉在电子邮件中表示，目前的目标是明年下半年在欧洲交付首批Model S和Model X：</blockquote></p><p>   Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022.  This means that Europe would be without Model S and Model X for a year and a half.</p><p><blockquote>你的Model X离交付越来越近了。我们目前预计北美以外的发货将于2022年下半年开始。这意味着欧洲将有一年半的时间没有Model S和Model X。</blockquote></p><p> Here’s the email in full:</p><p><blockquote>以下是电子邮件全文：</blockquote></p><p>   Hello [redacted],    We are contacting you regarding the timing of your Model X order. As we expand production capacity, the launch dates for markets outside of North America have been postponed. We will inform you of the delivery times through your Tesla account when production begins.    Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022.    In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America.    The price of your Model X will continue to be the same as it was when you placed your order, unless your vehicle configuration has been changed. To apply your order fee to another model, or to receive a full refund, request a call to speak directly to a Tesla representative.    We apologize for any inconvenience this may cause.    Kind regards,    Your Tesla Team Testa </p><p><blockquote>您好【已编辑】，我们正在就您订购Model X的时间与您联系。随着我们扩大产能，北美以外市场的上市日期已经推迟。当生产开始时，我们将通过您的特斯拉帐户通知您交货时间。你的Model X离交付越来越近了。我们目前预计北美以外的发货将于2022年下半年开始。为了尽可能加快现有订单（包括您的Model X订单）的交付，我们目前不再接受来自北美以外市场的Model S和Model X的新订单。您的Model X的价格将继续与您下订单时相同，除非您的车辆配置发生了变化。要将您的订单费用应用于其他型号，或获得全额退款，请要求看涨期权直接与特斯拉代表联系。对于由此可能造成的任何不便，我们深表歉意。亲切的问候，您的特斯拉团队Testa</blockquote></p><p></p>","source":"lsy1627037122897","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla stops taking Model S and Model X orders outside North America<blockquote>特斯拉停止接受北美以外地区Model S和Model X订单</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Electrek</strong><span class=\"h-time small\">2021-12-10 23:01</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outside North America.</p><p><blockquote>特斯拉今天向潜在买家宣布，停止接受北美以外的新Model S和Model X订单。</blockquote></p><p> It now expects deliveries in other markets to start during the second half of 2022.</p><p><blockquote>目前预计其他市场的交付将于2022年下半年开始。</blockquote></p><p> The news comes from an email that Tesla started sending out to people who have Model S and Model X vehicles on order in Europe.</p><p><blockquote>该消息来自特斯拉开始向在欧洲订购Model S和Model X车辆的人发送的一封电子邮件。</blockquote></p><p> Tesla writes in the email that it is not accepting any new orders (translated from German):</p><p><blockquote>特斯拉在电子邮件中写道，它不接受任何新订单（翻译自德语）：</blockquote></p><p>   In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America.  This is in response to Tesla likely having a large backlog of Model S/X orders in Europe and other markets, where there has been no new Model S/X shipment in a year.</p><p><blockquote>为了尽可能加快现有订单（包括您的Model X订单）的交付，我们目前不再接受来自北美以外市场的Model S和Model X的新订单。这是为了应对特斯拉可能在欧洲和其他市场积压了大量Model S/X订单，这些市场已经一年没有新的Model S/X出货。</blockquote></p><p> Tesla shut down Model S and Model X production in January of last year to update the vehicles.</p><p><blockquote>特斯拉于去年1月关闭了Model S和Model X的生产以更新车辆。</blockquote></p><p> During that year, the automaker kept taking new orders, but production was delayed with new Model S starting to slowly come off the assembly line in June and&nbsp;Model X in October.</p><p><blockquote>那一年，该汽车制造商不断接受新订单，但生产被推迟，新款Model S于6月开始慢慢下线，Model X于10月开始下线。</blockquote></p><p> Tesla is still catching up to the backlog in North America while new orders kept coming in from Europe and Asia.</p><p><blockquote>特斯拉仍在追赶北美的积压订单，而新订单不断来自欧洲和亚洲。</blockquote></p><p> In the email, Tesla says that it now aims to deliver the first Model S and Model X in Europe during the second half of next year:</p><p><blockquote>特斯拉在电子邮件中表示，目前的目标是明年下半年在欧洲交付首批Model S和Model X：</blockquote></p><p>   Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022.  This means that Europe would be without Model S and Model X for a year and a half.</p><p><blockquote>你的Model X离交付越来越近了。我们目前预计北美以外的发货将于2022年下半年开始。这意味着欧洲将有一年半的时间没有Model S和Model X。</blockquote></p><p> Here’s the email in full:</p><p><blockquote>以下是电子邮件全文：</blockquote></p><p>   Hello [redacted],    We are contacting you regarding the timing of your Model X order. As we expand production capacity, the launch dates for markets outside of North America have been postponed. We will inform you of the delivery times through your Tesla account when production begins.    Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022.    In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America.    The price of your Model X will continue to be the same as it was when you placed your order, unless your vehicle configuration has been changed. To apply your order fee to another model, or to receive a full refund, request a call to speak directly to a Tesla representative.    We apologize for any inconvenience this may cause.    Kind regards,    Your Tesla Team Testa </p><p><blockquote>您好【已编辑】，我们正在就您订购Model X的时间与您联系。随着我们扩大产能，北美以外市场的上市日期已经推迟。当生产开始时，我们将通过您的特斯拉帐户通知您交货时间。你的Model X离交付越来越近了。我们目前预计北美以外的发货将于2022年下半年开始。为了尽可能加快现有订单（包括您的Model X订单）的交付，我们目前不再接受来自北美以外市场的Model S和Model X的新订单。您的Model X的价格将继续与您下订单时相同，除非您的车辆配置发生了变化。要将您的订单费用应用于其他型号，或获得全额退款，请要求看涨期权直接与特斯拉代表联系。对于由此可能造成的任何不便，我们深表歉意。亲切的问候，您的特斯拉团队Testa</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://electrek.co/2021/12/10/tesla-stops-taking-model-s-x-orders-outside-north-america/\">Electrek</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://electrek.co/2021/12/10/tesla-stops-taking-model-s-x-orders-outside-north-america/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165282830","content_text":"Tesla announced to potential buyers today that it stopped taking new Model S and Model X orders outside North America.\nIt now expects deliveries in other markets to start during the second half of 2022.\nThe news comes from an email that Tesla started sending out to people who have Model S and Model X vehicles on order in Europe.\nTesla writes in the email that it is not accepting any new orders (translated from German):\n\n In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America.\n\nThis is in response to Tesla likely having a large backlog of Model S/X orders in Europe and other markets, where there has been no new Model S/X shipment in a year.\nTesla shut down Model S and Model X production in January of last year to update the vehicles.\nDuring that year, the automaker kept taking new orders, but production was delayed with new Model S starting to slowly come off the assembly line in June and Model X in October.\nTesla is still catching up to the backlog in North America while new orders kept coming in from Europe and Asia.\nIn the email, Tesla says that it now aims to deliver the first Model S and Model X in Europe during the second half of next year:\n\n Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022.\n\nThis means that Europe would be without Model S and Model X for a year and a half.\nHere’s the email in full:\n\n Hello [redacted],\n\n\n We are contacting you regarding the timing of your Model X order. As we expand production capacity, the launch dates for markets outside of North America have been postponed. We will inform you of the delivery times through your Tesla account when production begins.\n\n\n Your Model X is getting closer to delivery. We currently expect shipments outside of North America to begin in the second half of 2022.\n\n\n In order to expedite the delivery of existing orders, including your Model X order, as much as possible, we are currently no longer accepting new orders for the Model S and Model X from markets outside of North America.\n\n\n The price of your Model X will continue to be the same as it was when you placed your order, unless your vehicle configuration has been changed. To apply your order fee to another model, or to receive a full refund, request a call to speak directly to a Tesla representative.\n\n\n We apologize for any inconvenience this may cause.\n\n\n Kind regards,\n\n\n Your Tesla Team Testa","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3323,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602540202,"gmtCreate":1639046819835,"gmtModify":1639046819980,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602540202","repostId":"1128116582","repostType":4,"isVote":1,"tweetType":1,"viewCount":903,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602014612,"gmtCreate":1638939503237,"gmtModify":1638939503339,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602014612","repostId":"1110034472","repostType":4,"repost":{"id":"1110034472","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638934503,"share":"https://www.laohu8.com/m/news/1110034472?lang=zh_CN&edition=full","pubTime":"2021-12-08 11:35","market":"us","language":"en","title":"Alibaba shares fell nearly 5% in Hong Kong market<blockquote>阿里巴巴-SW股价在香港市场下跌近5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1110034472","media":"Tiger Newspress","summary":"Alibaba shares fell nearly 5% in Hong Kong market.\nThe stock rose more than 12% on Tuesday.","content":"<p>Alibaba&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;5%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;market.</p><p><blockquote>阿里巴巴-SW股价在香港市场下跌近5%。</blockquote></p><p> The&nbsp;stock&nbsp;rose&nbsp;more&nbsp;than&nbsp;12%&nbsp;on&nbsp;Tuesday.<img src=\"https://static.tigerbbs.com/7164e9b37a74a667396e8d0d739f70b5\" tg-width=\"708\" tg-height=\"600\" width=\"100%\" height=\"auto\"></p><p><blockquote>该股周二涨超12%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba shares fell nearly 5% in Hong Kong market<blockquote>阿里巴巴-SW股价在香港市场下跌近5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba shares fell nearly 5% in Hong Kong market<blockquote>阿里巴巴-SW股价在香港市场下跌近5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-08 11:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Alibaba&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;5%&nbsp;in&nbsp;Hong&nbsp;Kong&nbsp;market.</p><p><blockquote>阿里巴巴-SW股价在香港市场下跌近5%。</blockquote></p><p> The&nbsp;stock&nbsp;rose&nbsp;more&nbsp;than&nbsp;12%&nbsp;on&nbsp;Tuesday.<img src=\"https://static.tigerbbs.com/7164e9b37a74a667396e8d0d739f70b5\" tg-width=\"708\" tg-height=\"600\" width=\"100%\" height=\"auto\"></p><p><blockquote>该股周二涨超12%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09988":"阿里巴巴-W","BABA":"阿里巴巴"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110034472","content_text":"Alibaba shares fell nearly 5% in Hong Kong market.\nThe stock rose more than 12% on Tuesday.","news_type":1,"symbols_score_info":{"09988":0.9,"BABA":0.9}},"isVote":1,"tweetType":1,"viewCount":1117,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606912472,"gmtCreate":1638808613038,"gmtModify":1638808613175,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606912472","repostId":"1167580246","repostType":4,"repost":{"id":"1167580246","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638802452,"share":"https://www.laohu8.com/m/news/1167580246?lang=zh_CN&edition=full","pubTime":"2021-12-06 22:54","market":"us","language":"en","title":"Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1167580246","media":"Tiger Newspress","summary":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Se","content":"<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries&nbsp;and&nbsp;ON&nbsp;Semiconductor fell between 2% and 7%.</p><p><blockquote>半导体股早盘下跌。英伟达、台积电、ASML、AMD、赛灵思、格芯和安森美半导体跌幅在2%至7%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks dipped in morning trading<blockquote>半导体股早盘下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-06 22:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries&nbsp;and&nbsp;ON&nbsp;Semiconductor fell between 2% and 7%.</p><p><blockquote>半导体股早盘下跌。英伟达、台积电、ASML、AMD、赛灵思、格芯和安森美半导体跌幅在2%至7%之间。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fd417bf4091570cb848a432d4946ce4\" tg-width=\"400\" tg-height=\"714\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRVL":"迈威尔科技","GFS":"GLOBALFOUNDRIES Inc.","AMD":"美国超微公司","NVDA":"英伟达","ADI":"亚德诺","QCOM":"高通","MU":"美光科技","TXN":"德州仪器","ASML":"阿斯麦","ON":"安森美半导体","TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167580246","content_text":"Semiconductor stocks dipped in morning trading.Nvidia,TSMC,ASML,AMD,Xilinx,Globalfoundries and ON Semiconductor fell between 2% and 7%.","news_type":1,"symbols_score_info":{"TXN":0.9,"ASML":0.9,"ON":0.9,"ADI":0.9,"GFS":0.9,"QCOM":0.9,"AMD":0.9,"NVDA":0.9,"XLNX":0.9,"MRVL":0.9,"MU":0.9,"TSM":0.9}},"isVote":1,"tweetType":1,"viewCount":822,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601166584,"gmtCreate":1638498825733,"gmtModify":1638498825733,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601166584","repostId":"1137450856","repostType":4,"isVote":1,"tweetType":1,"viewCount":1190,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609477956,"gmtCreate":1638322081879,"gmtModify":1638322081950,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/609477956","repostId":"2188535363","repostType":4,"isVote":1,"tweetType":1,"viewCount":457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609699402,"gmtCreate":1638274629509,"gmtModify":1638274629576,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609699402","repostId":"1136264859","repostType":4,"repost":{"id":"1136264859","kind":"news","pubTimestamp":1638272133,"share":"https://www.laohu8.com/m/news/1136264859?lang=zh_CN&edition=full","pubTime":"2021-11-30 19:35","market":"us","language":"en","title":"Roku’s Beaten-Down Stock Is Still a Winner, Analysts Say<blockquote>分析师表示，Roku遭受重创的股票仍然是赢家</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1136264859","media":"Barrons","summary":"Roku shares have floundered in recent weeks as the stay-at-home trade unraveled. But a few analysts ","content":"<p>Roku&nbsp;shares have floundered in recent weeks as the stay-at-home trade unraveled. But a few analysts say the dip will prove temporary.</p><p><blockquote>最近几周，随着居家交易的瓦解，Roku股价陷入困境。但一些分析师表示，下跌将是暂时的。</blockquote></p><p> Benchmark analyst Daniel Kurnos wrote in a note on Monday that sentiment on Wall Street has been negative, to say the least, with Roku’s stock price (ticker: ROKU) cut in half from its one-year intraday high. Analysts have been taking a less upbeat view of Roku’s postpandemic prospects, but Kurnos also noted some tension ahead of a Dec. 9 deadline for Roku and&nbsp;Alphabet’s&nbsp;(GOOGL) YouTube to reach a deal to keep the app on the Roku platform.</p><p><blockquote>Benchmark分析师Daniel Kurnos周一在一份报告中写道，至少可以说，华尔街的情绪一直是负面的，Roku（股票代码：Roku）的股价从一年盘中高点下跌了一半。分析师对Roku大流行后的前景一直不太乐观，但Kurnos也指出，在12月9日Roku和Alphabet（GOOGL）的YouTube达成协议以将该应用程序保留在Roku平台上的最后期限之前，存在一些紧张局势。</blockquote></p><p> Roku stock, which Kurnos rates at Buy, was down 1.7% to $231.28 on Monday. His target for the stock price is $525, which implies a gain of nearly127%, for those counting.</p><p><blockquote>Kurnos将Roku股票评级为买入，周一下跌1.7%，至231.28美元。他对股价的目标是525美元，对于那些计算在内的人来说，这意味着近127%的涨幅。</blockquote></p><p> “We think this is an ideal setup for the stock, especially since our channel checks indicate a much healthier in-stock level of Roku TVs at both&nbsp;Walmart&nbsp;and&nbsp;Best Buy&nbsp;than feared, while we think a Google-Roku resolution could be in the offing even if a temporary blackout occurs,” Kurnos wrote.</p><p><blockquote>“我们认为这是库存的理想设置，特别是因为我们的渠道检查表明沃尔玛和百思买的Roku电视库存水平比预期的要健康得多，而我们认为谷歌-Roku的解决方案可能即将出台即使发生暂时停电，”库诺斯写道。</blockquote></p><p> While he thinks Roku could temporarily drop the YouTube app, he argued there is too much at stake for both parties not to find a compromise, possibly before the end of the year.</p><p><blockquote>虽然他认为Roku可能会暂时放弃YouTube应用程序，但他认为，如果双方不在今年年底之前找到妥协方案，风险太大。</blockquote></p><p> “Not only would this be a positive catalyst for the stock but it would also lessen the fears around a potential Roku-Amazon showdown in the future,” Kurnos wrote.</p><p><blockquote>库诺斯写道：“这不仅会成为该股的积极催化剂，还会减轻人们对未来Roku与亚马逊摊牌的担忧。”</blockquote></p><p> Roku sells devices that turn televisions into smart TVs, accessing the Roku platform via the internet. It has deals in place with apps, in some cases getting a cut of subscriptions and advertising dollars spent on its platform.</p><p><blockquote>Roku销售将电视变成智能电视的设备，通过互联网访问Roku平台。它与应用程序达成了协议，在某些情况下，可以从其平台上的订阅和广告费中获得一部分。</blockquote></p><p> Kurnos likened the situation to the spring of 2020, when those betting against Roku stock argued the company would see increased competition and was losing leverage in its negotiations for streaming services. The company later reached deals with&nbsp;AT&amp;T’s&nbsp;HBO Max and&nbsp;Comcast’s&nbsp;Peacock services.</p><p><blockquote>Kurnos将这种情况比作2020年春天，当时那些做空Roku股票的人认为，该公司将面临竞争加剧，并在流媒体服务谈判中失去影响力。该公司后来与AT&amp;T的HBO Max和康卡斯特的Peacock services达成了协议。</blockquote></p><p> “Roku has one of the most advanced, self-contained ecosystems within streaming, and thus we expect them to be a share gainer, with levers to pull by making additional options available only if participants utilize the OneView platform, for example,” he wrote, referring to Roku’s OneView ad-buying platform.</p><p><blockquote>“Roku拥有流媒体领域最先进、独立的生态系统之一，因此我们预计他们将成为份额赢家，例如，只有当参与者使用OneView平台时，才能通过提供额外的选项来拉动杠杆，”他写道，指的是Roku的OneView广告购买平台。</blockquote></p><p> Also on Monday, Bank of America Securities analyst Ruplu Bhattacharya cut his price target to $360 from $400 but maintained a Buy rating. Near-term headwinds the company faces—think supply chain and logistics challenges and lower spending from advertisers in areas such as consumer packaged goods, car manufacturing, and restaurants—are transitory, he said.</p><p><blockquote>同样在周一，美国银行证券分析师Ruplu Bhattacharya将目标价从400美元下调至360美元，但维持买入评级。他表示，该公司近期面临的不利因素——例如供应链和物流挑战以及广告商在消费品、汽车制造和餐馆等领域的支出减少——都是暂时的。</blockquote></p><p> Roku’s competitive advantages remain intact, Bhattacharya said.</p><p><blockquote>巴塔查里亚说，Roku的竞争优势仍然完好无损。</blockquote></p><p> “In the long-term, we expect Roku revenues to benefit from active account growth driven by geographic expansion into international markets, and increasing content,” Bhattacharya wrote. “In addition, Advertising revenues should continue to benefit from the shift of Ad spend from Linear TV to [over-the-top], as well as from Roku’s proprietary viewership data and OneView’s omni channel capabilities.”</p><p><blockquote>巴塔查里亚写道：“从长远来看，我们预计Roku收入将受益于国际市场地理扩张和内容增加推动的活跃账户增长。”“此外，广告收入应该会继续受益于广告支出从线性电视向[过度]的转变，以及Roku专有的收视率数据和OneView的全渠道功能。”</blockquote></p><p> D.A. Davidson analysts called Roku stock their top pick for the 2021 holiday season. They reiterated a Buy rating and $550 price target, saying supply-chain challenges could benefit Roku, in the sense that subscriptions to streaming-services such as Disney+, HBO Max, and&nbsp;Netflix&nbsp;could be popular gifts.</p><p><blockquote>D.A.Davidson分析师称Roku股票是2021年假日季的首选。他们重申了买入评级和550美元的目标价，称供应链挑战可能有利于Roku，因为订阅Disney+、HBO Max和Netflix等流媒体服务可能是受欢迎的礼物。</blockquote></p><p> “We believe this could benefit Roku on multiple fronts,” they wrote.</p><p><blockquote>他们写道：“我们相信这可以在多个方面使Roku受益。”</blockquote></p><p> They argued Roku’s strong position as a smart-TV operating-system provider could mean users who get streaming-service gift cards could sign up on the Roku platform, driving revenue to Roku. Plus, if streaming services want to steer potential gift givers to their own offerings, such firms might look to advertise on Roku’s platform, they said.</p><p><blockquote>他们认为，Roku作为智能电视操作系统提供商的强势地位可能意味着获得流媒体服务礼品卡的用户可以在Roku平台上注册，从而增加Roku的收入。此外，他们表示，如果流媒体服务希望引导潜在的送礼者使用自己的产品，这些公司可能会考虑在Roku的平台上做广告。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku’s Beaten-Down Stock Is Still a Winner, Analysts Say<blockquote>分析师表示，Roku遭受重创的股票仍然是赢家</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku’s Beaten-Down Stock Is Still a Winner, Analysts Say<blockquote>分析师表示，Roku遭受重创的股票仍然是赢家</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-30 19:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Roku&nbsp;shares have floundered in recent weeks as the stay-at-home trade unraveled. But a few analysts say the dip will prove temporary.</p><p><blockquote>最近几周，随着居家交易的瓦解，Roku股价陷入困境。但一些分析师表示，下跌将是暂时的。</blockquote></p><p> Benchmark analyst Daniel Kurnos wrote in a note on Monday that sentiment on Wall Street has been negative, to say the least, with Roku’s stock price (ticker: ROKU) cut in half from its one-year intraday high. Analysts have been taking a less upbeat view of Roku’s postpandemic prospects, but Kurnos also noted some tension ahead of a Dec. 9 deadline for Roku and&nbsp;Alphabet’s&nbsp;(GOOGL) YouTube to reach a deal to keep the app on the Roku platform.</p><p><blockquote>Benchmark分析师Daniel Kurnos周一在一份报告中写道，至少可以说，华尔街的情绪一直是负面的，Roku（股票代码：Roku）的股价从一年盘中高点下跌了一半。分析师对Roku大流行后的前景一直不太乐观，但Kurnos也指出，在12月9日Roku和Alphabet（GOOGL）的YouTube达成协议以将该应用程序保留在Roku平台上的最后期限之前，存在一些紧张局势。</blockquote></p><p> Roku stock, which Kurnos rates at Buy, was down 1.7% to $231.28 on Monday. His target for the stock price is $525, which implies a gain of nearly127%, for those counting.</p><p><blockquote>Kurnos将Roku股票评级为买入，周一下跌1.7%，至231.28美元。他对股价的目标是525美元，对于那些计算在内的人来说，这意味着近127%的涨幅。</blockquote></p><p> “We think this is an ideal setup for the stock, especially since our channel checks indicate a much healthier in-stock level of Roku TVs at both&nbsp;Walmart&nbsp;and&nbsp;Best Buy&nbsp;than feared, while we think a Google-Roku resolution could be in the offing even if a temporary blackout occurs,” Kurnos wrote.</p><p><blockquote>“我们认为这是库存的理想设置，特别是因为我们的渠道检查表明沃尔玛和百思买的Roku电视库存水平比预期的要健康得多，而我们认为谷歌-Roku的解决方案可能即将出台即使发生暂时停电，”库诺斯写道。</blockquote></p><p> While he thinks Roku could temporarily drop the YouTube app, he argued there is too much at stake for both parties not to find a compromise, possibly before the end of the year.</p><p><blockquote>虽然他认为Roku可能会暂时放弃YouTube应用程序，但他认为，如果双方不在今年年底之前找到妥协方案，风险太大。</blockquote></p><p> “Not only would this be a positive catalyst for the stock but it would also lessen the fears around a potential Roku-Amazon showdown in the future,” Kurnos wrote.</p><p><blockquote>库诺斯写道：“这不仅会成为该股的积极催化剂，还会减轻人们对未来Roku与亚马逊摊牌的担忧。”</blockquote></p><p> Roku sells devices that turn televisions into smart TVs, accessing the Roku platform via the internet. It has deals in place with apps, in some cases getting a cut of subscriptions and advertising dollars spent on its platform.</p><p><blockquote>Roku销售将电视变成智能电视的设备，通过互联网访问Roku平台。它与应用程序达成了协议，在某些情况下，可以从其平台上的订阅和广告费中获得一部分。</blockquote></p><p> Kurnos likened the situation to the spring of 2020, when those betting against Roku stock argued the company would see increased competition and was losing leverage in its negotiations for streaming services. The company later reached deals with&nbsp;AT&amp;T’s&nbsp;HBO Max and&nbsp;Comcast’s&nbsp;Peacock services.</p><p><blockquote>Kurnos将这种情况比作2020年春天，当时那些做空Roku股票的人认为，该公司将面临竞争加剧，并在流媒体服务谈判中失去影响力。该公司后来与AT&amp;T的HBO Max和康卡斯特的Peacock services达成了协议。</blockquote></p><p> “Roku has one of the most advanced, self-contained ecosystems within streaming, and thus we expect them to be a share gainer, with levers to pull by making additional options available only if participants utilize the OneView platform, for example,” he wrote, referring to Roku’s OneView ad-buying platform.</p><p><blockquote>“Roku拥有流媒体领域最先进、独立的生态系统之一，因此我们预计他们将成为份额赢家，例如，只有当参与者使用OneView平台时，才能通过提供额外的选项来拉动杠杆，”他写道，指的是Roku的OneView广告购买平台。</blockquote></p><p> Also on Monday, Bank of America Securities analyst Ruplu Bhattacharya cut his price target to $360 from $400 but maintained a Buy rating. Near-term headwinds the company faces—think supply chain and logistics challenges and lower spending from advertisers in areas such as consumer packaged goods, car manufacturing, and restaurants—are transitory, he said.</p><p><blockquote>同样在周一，美国银行证券分析师Ruplu Bhattacharya将目标价从400美元下调至360美元，但维持买入评级。他表示，该公司近期面临的不利因素——例如供应链和物流挑战以及广告商在消费品、汽车制造和餐馆等领域的支出减少——都是暂时的。</blockquote></p><p> Roku’s competitive advantages remain intact, Bhattacharya said.</p><p><blockquote>巴塔查里亚说，Roku的竞争优势仍然完好无损。</blockquote></p><p> “In the long-term, we expect Roku revenues to benefit from active account growth driven by geographic expansion into international markets, and increasing content,” Bhattacharya wrote. “In addition, Advertising revenues should continue to benefit from the shift of Ad spend from Linear TV to [over-the-top], as well as from Roku’s proprietary viewership data and OneView’s omni channel capabilities.”</p><p><blockquote>巴塔查里亚写道：“从长远来看，我们预计Roku收入将受益于国际市场地理扩张和内容增加推动的活跃账户增长。”“此外，广告收入应该会继续受益于广告支出从线性电视向[过度]的转变，以及Roku专有的收视率数据和OneView的全渠道功能。”</blockquote></p><p> D.A. Davidson analysts called Roku stock their top pick for the 2021 holiday season. They reiterated a Buy rating and $550 price target, saying supply-chain challenges could benefit Roku, in the sense that subscriptions to streaming-services such as Disney+, HBO Max, and&nbsp;Netflix&nbsp;could be popular gifts.</p><p><blockquote>D.A.Davidson分析师称Roku股票是2021年假日季的首选。他们重申了买入评级和550美元的目标价，称供应链挑战可能有利于Roku，因为订阅Disney+、HBO Max和Netflix等流媒体服务可能是受欢迎的礼物。</blockquote></p><p> “We believe this could benefit Roku on multiple fronts,” they wrote.</p><p><blockquote>他们写道：“我们相信这可以在多个方面使Roku受益。”</blockquote></p><p> They argued Roku’s strong position as a smart-TV operating-system provider could mean users who get streaming-service gift cards could sign up on the Roku platform, driving revenue to Roku. Plus, if streaming services want to steer potential gift givers to their own offerings, such firms might look to advertise on Roku’s platform, they said.</p><p><blockquote>他们认为，Roku作为智能电视操作系统提供商的强势地位可能意味着获得流媒体服务礼品卡的用户可以在Roku平台上注册，从而增加Roku的收入。此外，他们表示，如果流媒体服务希望引导潜在的送礼者使用自己的产品，这些公司可能会考虑在Roku的平台上做广告。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/roku-stock-price-buy-outlook-51638229560?mod=hp_LATEST\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ROKU":"Roku Inc"},"source_url":"https://www.barrons.com/articles/roku-stock-price-buy-outlook-51638229560?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136264859","content_text":"Roku shares have floundered in recent weeks as the stay-at-home trade unraveled. But a few analysts say the dip will prove temporary.\nBenchmark analyst Daniel Kurnos wrote in a note on Monday that sentiment on Wall Street has been negative, to say the least, with Roku’s stock price (ticker: ROKU) cut in half from its one-year intraday high. Analysts have been taking a less upbeat view of Roku’s postpandemic prospects, but Kurnos also noted some tension ahead of a Dec. 9 deadline for Roku and Alphabet’s (GOOGL) YouTube to reach a deal to keep the app on the Roku platform.\nRoku stock, which Kurnos rates at Buy, was down 1.7% to $231.28 on Monday. His target for the stock price is $525, which implies a gain of nearly127%, for those counting.\n“We think this is an ideal setup for the stock, especially since our channel checks indicate a much healthier in-stock level of Roku TVs at both Walmart and Best Buy than feared, while we think a Google-Roku resolution could be in the offing even if a temporary blackout occurs,” Kurnos wrote.\nWhile he thinks Roku could temporarily drop the YouTube app, he argued there is too much at stake for both parties not to find a compromise, possibly before the end of the year.\n“Not only would this be a positive catalyst for the stock but it would also lessen the fears around a potential Roku-Amazon showdown in the future,” Kurnos wrote.\nRoku sells devices that turn televisions into smart TVs, accessing the Roku platform via the internet. It has deals in place with apps, in some cases getting a cut of subscriptions and advertising dollars spent on its platform.\nKurnos likened the situation to the spring of 2020, when those betting against Roku stock argued the company would see increased competition and was losing leverage in its negotiations for streaming services. The company later reached deals with AT&T’s HBO Max and Comcast’s Peacock services.\n“Roku has one of the most advanced, self-contained ecosystems within streaming, and thus we expect them to be a share gainer, with levers to pull by making additional options available only if participants utilize the OneView platform, for example,” he wrote, referring to Roku’s OneView ad-buying platform.\nAlso on Monday, Bank of America Securities analyst Ruplu Bhattacharya cut his price target to $360 from $400 but maintained a Buy rating. Near-term headwinds the company faces—think supply chain and logistics challenges and lower spending from advertisers in areas such as consumer packaged goods, car manufacturing, and restaurants—are transitory, he said.\nRoku’s competitive advantages remain intact, Bhattacharya said.\n“In the long-term, we expect Roku revenues to benefit from active account growth driven by geographic expansion into international markets, and increasing content,” Bhattacharya wrote. “In addition, Advertising revenues should continue to benefit from the shift of Ad spend from Linear TV to [over-the-top], as well as from Roku’s proprietary viewership data and OneView’s omni channel capabilities.”\nD.A. Davidson analysts called Roku stock their top pick for the 2021 holiday season. They reiterated a Buy rating and $550 price target, saying supply-chain challenges could benefit Roku, in the sense that subscriptions to streaming-services such as Disney+, HBO Max, and Netflix could be popular gifts.\n“We believe this could benefit Roku on multiple fronts,” they wrote.\nThey argued Roku’s strong position as a smart-TV operating-system provider could mean users who get streaming-service gift cards could sign up on the Roku platform, driving revenue to Roku. Plus, if streaming services want to steer potential gift givers to their own offerings, such firms might look to advertise on Roku’s platform, they said.","news_type":1,"symbols_score_info":{"ROKU":0.9}},"isVote":1,"tweetType":1,"viewCount":624,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600664647,"gmtCreate":1638148320752,"gmtModify":1638148320817,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600664647","repostId":"1169118930","repostType":4,"repost":{"id":"1169118930","kind":"news","pubTimestamp":1638146156,"share":"https://www.laohu8.com/m/news/1169118930?lang=zh_CN&edition=full","pubTime":"2021-11-29 08:35","market":"us","language":"en","title":"IBM Cast Off Kyndryl. Here’s What Investors Should Do With the Stock<blockquote>IBM放弃了Kyndryl。以下是投资者应该如何处理该股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1169118930","media":"Marketwatch","summary":"A key part of IBM’s turnaround story was written in early November: packaging the company’s low-marg","content":"<p>A key part of IBM’s turnaround story was written in early November: packaging the company’s low-margin, negative-growth information-technology services business, giving it a cool-sounding name, and getting it off the income statement.</p><p><blockquote>IBM扭亏为盈的故事的一个关键部分是在11月初写的：将公司低利润、负增长的信息技术服务业务打包，给它起一个听起来很酷的名字，并将其从损益表中删除。</blockquote></p><p> That’s how Kyndryl Holdings (ticker: KD) was born. The new/old company is a leading player in the IT managed services business, running data centers and other IT operations for more than 4,000 customers.</p><p><blockquote>Kyndryl Holdings（股票代码：KD）就是这样诞生的。这家新/老公司是IT托管服务业务的领先企业，为4,000多家客户运营数据中心和其他IT运营。</blockquote></p><p> Kyndryl has 90,000 employees and dominates the sector. The company had $19.1 billion in revenue, on a pro forma basis, in 2020, about twice as much as rival DXC Technology (DXC), according to Kyndryl’s spinoff documents. It has an even bigger edge on peers such as Atos (ATO.France), HCL Technologies (532281.India), Tata Consultancy Services (532540.India), and Cognizant (CTSH).</p><p><blockquote>Kyndryl拥有90,000名员工，在该行业占据主导地位。根据Kyndryl的分拆文件，该公司2020年的预计收入为191亿美元，约为竞争对手DXC Technology(DXC)的两倍。它比Atos(ATO.France)、HCL Technologies(532281.India)、Tata Consultancy Services(532540.India)和Cognizant(CTSH)等同行更具优势。</blockquote></p><p> IBM stockholders got one share of Kyndryl for every five IBM shares held.</p><p><blockquote>IBM股东每持有五股IBM股票即可获得一股Kyndryl股票。</blockquote></p><p> Kyndryl CEO Martin Schroeter recently told Barron’s that he views the company as a “$19 billion start-up,” which is reconfiguring its business for a world in which more and more IT workloads are shifting to the cloud and away from data centers. He says the spinoff will let the company reposition itself for growth, using mergers and acquisitions and internal development to adjust its business mix.</p><p><blockquote>Kyndryl首席执行官Martin Schroeter最近告诉《巴伦周刊》，他将该公司视为一家“价值190亿美元的初创公司”，该公司正在重新配置其业务，以适应越来越多的IT工作负载从数据中心转移到云的世界。他表示，分拆将使公司重新定位增长，利用并购和内部发展来调整其业务组合。</blockquote></p><p> But Kyndryl is having trouble finding its own independent investor base. In late October, the stock traded above $40 on a “when issued” basis. Kyndryl opened for trading on Nov. 4 at $28.41, and has continued to fall from there.</p><p><blockquote>但Kyndryl很难找到自己的独立投资者基础。10月下旬，该股“发行时”交易价格高于40美元。Kyndryl于11月4日开盘价为28.41美元，此后持续下跌。</blockquote></p><p> At a recent price of $17.30, Kyndryl has a market cap of just $3.9 billion. With $1.2 billion in net debt, its enterprise value comes to $5.1 billion. That gives the company an enterprise value to sales multiple of less than 0.3. There are just four companies in the S&amp;P 500 index with a multiple lower than that. DXC trades for about 0.7 times projected revenue for its March 2022 fiscal year.</p><p><blockquote>以最近17.30美元的价格计算，Kyndryl的市值仅为39亿美元。净债务为12亿美元，其企业价值达到51亿美元。这使得该公司的企业价值与销售额的倍数小于0.3。标普500指数中只有四家公司的市盈率低于这一数字。DXC的交易价格约为2022年3月财年预计收入的0.7倍。</blockquote></p><p> But there are reasons that IBM investors—and others—are shunning the spun-off stock. For one thing, IBM has been attractive to investors in part for its 5.6% dividend yield, the highest of any company in the Dow Jones Industrial Average, and one of the highest in the S&amp;P 500. Anyone who owns IBM for the yield isn’t interested in Kyndryl stock.</p><p><blockquote>但IBM投资者和其他人回避分拆股票是有原因的。一方面，IBM对投资者的吸引力部分在于其5.6%的股息收益率，这是道琼斯工业平均指数中最高的公司，也是标普500中最高的公司之一。任何为了收益而持有IBM的人都对Kyndryl股票不感兴趣。</blockquote></p><p> Another issue: Kyndryl doesn’t expect to show growth before 2025. The company projects 2021 revenue of $18.5 billion to $18.7 billion; at the midpoint, that’s a 2.6% decline from 2020’s level. Kyndryl sees adjusted earnings before interest, taxes, depreciation, and amortization, or Ebitda, of $2.8 billion to $2.9 billion.</p><p><blockquote>另一个问题是：Kyndryl预计在2025年之前不会出现增长。该公司预计2021年收入为185亿美元至187亿美元；按中点计算，较2020年水平下降2.6%。Kyndryl预计调整后息税折旧摊销前利润(Ebitda)为28亿至29亿美元。</blockquote></p><p> For investors, there’s little incentive to own a shrinking IT services company without a dividend yield. Short of a private-equity buyout—with the idea of revamping the company out of sight of the public markets—there are few near-term catalysts for Kyndryl stock.</p><p><blockquote>对于投资者来说，在没有股息收益率的情况下，几乎没有动力拥有一家萎缩的IT服务公司。除了私募股权收购（即在公开市场看不到的情况下改造公司）之外，Kyndryl股票的近期催化剂很少。</blockquote></p><p> IBM shareholders have plenty of potential upside from that company’s core business. They don’t need to hold Kyndryl stock.</p><p><blockquote>IBM股东从该公司的核心业务中获得了很大的潜在收益。他们不需要持有Kyndryl股票。</blockquote></p><p></p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IBM Cast Off Kyndryl. Here’s What Investors Should Do With the Stock<blockquote>IBM放弃了Kyndryl。以下是投资者应该如何处理该股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIBM Cast Off Kyndryl. Here’s What Investors Should Do With the Stock<blockquote>IBM放弃了Kyndryl。以下是投资者应该如何处理该股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Marketwatch</strong><span class=\"h-time small\">2021-11-29 08:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>A key part of IBM’s turnaround story was written in early November: packaging the company’s low-margin, negative-growth information-technology services business, giving it a cool-sounding name, and getting it off the income statement.</p><p><blockquote>IBM扭亏为盈的故事的一个关键部分是在11月初写的：将公司低利润、负增长的信息技术服务业务打包，给它起一个听起来很酷的名字，并将其从损益表中删除。</blockquote></p><p> That’s how Kyndryl Holdings (ticker: KD) was born. The new/old company is a leading player in the IT managed services business, running data centers and other IT operations for more than 4,000 customers.</p><p><blockquote>Kyndryl Holdings（股票代码：KD）就是这样诞生的。这家新/老公司是IT托管服务业务的领先企业，为4,000多家客户运营数据中心和其他IT运营。</blockquote></p><p> Kyndryl has 90,000 employees and dominates the sector. The company had $19.1 billion in revenue, on a pro forma basis, in 2020, about twice as much as rival DXC Technology (DXC), according to Kyndryl’s spinoff documents. It has an even bigger edge on peers such as Atos (ATO.France), HCL Technologies (532281.India), Tata Consultancy Services (532540.India), and Cognizant (CTSH).</p><p><blockquote>Kyndryl拥有90,000名员工，在该行业占据主导地位。根据Kyndryl的分拆文件，该公司2020年的预计收入为191亿美元，约为竞争对手DXC Technology(DXC)的两倍。它比Atos(ATO.France)、HCL Technologies(532281.India)、Tata Consultancy Services(532540.India)和Cognizant(CTSH)等同行更具优势。</blockquote></p><p> IBM stockholders got one share of Kyndryl for every five IBM shares held.</p><p><blockquote>IBM股东每持有五股IBM股票即可获得一股Kyndryl股票。</blockquote></p><p> Kyndryl CEO Martin Schroeter recently told Barron’s that he views the company as a “$19 billion start-up,” which is reconfiguring its business for a world in which more and more IT workloads are shifting to the cloud and away from data centers. He says the spinoff will let the company reposition itself for growth, using mergers and acquisitions and internal development to adjust its business mix.</p><p><blockquote>Kyndryl首席执行官Martin Schroeter最近告诉《巴伦周刊》，他将该公司视为一家“价值190亿美元的初创公司”，该公司正在重新配置其业务，以适应越来越多的IT工作负载从数据中心转移到云的世界。他表示，分拆将使公司重新定位增长，利用并购和内部发展来调整其业务组合。</blockquote></p><p> But Kyndryl is having trouble finding its own independent investor base. In late October, the stock traded above $40 on a “when issued” basis. Kyndryl opened for trading on Nov. 4 at $28.41, and has continued to fall from there.</p><p><blockquote>但Kyndryl很难找到自己的独立投资者基础。10月下旬，该股“发行时”交易价格高于40美元。Kyndryl于11月4日开盘价为28.41美元，此后持续下跌。</blockquote></p><p> At a recent price of $17.30, Kyndryl has a market cap of just $3.9 billion. With $1.2 billion in net debt, its enterprise value comes to $5.1 billion. That gives the company an enterprise value to sales multiple of less than 0.3. There are just four companies in the S&amp;P 500 index with a multiple lower than that. DXC trades for about 0.7 times projected revenue for its March 2022 fiscal year.</p><p><blockquote>以最近17.30美元的价格计算，Kyndryl的市值仅为39亿美元。净债务为12亿美元，其企业价值达到51亿美元。这使得该公司的企业价值与销售额的倍数小于0.3。标普500指数中只有四家公司的市盈率低于这一数字。DXC的交易价格约为2022年3月财年预计收入的0.7倍。</blockquote></p><p> But there are reasons that IBM investors—and others—are shunning the spun-off stock. For one thing, IBM has been attractive to investors in part for its 5.6% dividend yield, the highest of any company in the Dow Jones Industrial Average, and one of the highest in the S&amp;P 500. Anyone who owns IBM for the yield isn’t interested in Kyndryl stock.</p><p><blockquote>但IBM投资者和其他人回避分拆股票是有原因的。一方面，IBM对投资者的吸引力部分在于其5.6%的股息收益率，这是道琼斯工业平均指数中最高的公司，也是标普500中最高的公司之一。任何为了收益而持有IBM的人都对Kyndryl股票不感兴趣。</blockquote></p><p> Another issue: Kyndryl doesn’t expect to show growth before 2025. The company projects 2021 revenue of $18.5 billion to $18.7 billion; at the midpoint, that’s a 2.6% decline from 2020’s level. Kyndryl sees adjusted earnings before interest, taxes, depreciation, and amortization, or Ebitda, of $2.8 billion to $2.9 billion.</p><p><blockquote>另一个问题是：Kyndryl预计在2025年之前不会出现增长。该公司预计2021年收入为185亿美元至187亿美元；按中点计算，较2020年水平下降2.6%。Kyndryl预计调整后息税折旧摊销前利润(Ebitda)为28亿至29亿美元。</blockquote></p><p> For investors, there’s little incentive to own a shrinking IT services company without a dividend yield. Short of a private-equity buyout—with the idea of revamping the company out of sight of the public markets—there are few near-term catalysts for Kyndryl stock.</p><p><blockquote>对于投资者来说，在没有股息收益率的情况下，几乎没有动力拥有一家萎缩的IT服务公司。除了私募股权收购（即在公开市场看不到的情况下改造公司）之外，Kyndryl股票的近期催化剂很少。</blockquote></p><p> IBM shareholders have plenty of potential upside from that company’s core business. They don’t need to hold Kyndryl stock.</p><p><blockquote>IBM股东从该公司的核心业务中获得了很大的潜在收益。他们不需要持有Kyndryl股票。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/articles/ibm-kyndryl-stock-what-to-do-51637798963?mod=newsviewer_click_seemore\">Marketwatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KD":"Kyndryl","IBM":"IBM"},"source_url":"https://www.marketwatch.com/articles/ibm-kyndryl-stock-what-to-do-51637798963?mod=newsviewer_click_seemore","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1169118930","content_text":"A key part of IBM’s turnaround story was written in early November: packaging the company’s low-margin, negative-growth information-technology services business, giving it a cool-sounding name, and getting it off the income statement.\nThat’s how Kyndryl Holdings (ticker: KD) was born. The new/old company is a leading player in the IT managed services business, running data centers and other IT operations for more than 4,000 customers.\nKyndryl has 90,000 employees and dominates the sector. The company had $19.1 billion in revenue, on a pro forma basis, in 2020, about twice as much as rival DXC Technology (DXC), according to Kyndryl’s spinoff documents. It has an even bigger edge on peers such as Atos (ATO.France), HCL Technologies (532281.India), Tata Consultancy Services (532540.India), and Cognizant (CTSH).\nIBM stockholders got one share of Kyndryl for every five IBM shares held.\nKyndryl CEO Martin Schroeter recently told Barron’s that he views the company as a “$19 billion start-up,” which is reconfiguring its business for a world in which more and more IT workloads are shifting to the cloud and away from data centers. He says the spinoff will let the company reposition itself for growth, using mergers and acquisitions and internal development to adjust its business mix.\nBut Kyndryl is having trouble finding its own independent investor base. In late October, the stock traded above $40 on a “when issued” basis. Kyndryl opened for trading on Nov. 4 at $28.41, and has continued to fall from there.\nAt a recent price of $17.30, Kyndryl has a market cap of just $3.9 billion. With $1.2 billion in net debt, its enterprise value comes to $5.1 billion. That gives the company an enterprise value to sales multiple of less than 0.3. There are just four companies in the S&P 500 index with a multiple lower than that. DXC trades for about 0.7 times projected revenue for its March 2022 fiscal year.\nBut there are reasons that IBM investors—and others—are shunning the spun-off stock. For one thing, IBM has been attractive to investors in part for its 5.6% dividend yield, the highest of any company in the Dow Jones Industrial Average, and one of the highest in the S&P 500. Anyone who owns IBM for the yield isn’t interested in Kyndryl stock.\nAnother issue: Kyndryl doesn’t expect to show growth before 2025. The company projects 2021 revenue of $18.5 billion to $18.7 billion; at the midpoint, that’s a 2.6% decline from 2020’s level. Kyndryl sees adjusted earnings before interest, taxes, depreciation, and amortization, or Ebitda, of $2.8 billion to $2.9 billion.\nFor investors, there’s little incentive to own a shrinking IT services company without a dividend yield. Short of a private-equity buyout—with the idea of revamping the company out of sight of the public markets—there are few near-term catalysts for Kyndryl stock.\nIBM shareholders have plenty of potential upside from that company’s core business. They don’t need to hold Kyndryl stock.","news_type":1,"symbols_score_info":{"KD":0.9,"IBM":0.9}},"isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600994356,"gmtCreate":1638028692653,"gmtModify":1638028692758,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600994356","repostId":"1187736093","repostType":4,"repost":{"id":"1187736093","kind":"news","pubTimestamp":1637973799,"share":"https://www.laohu8.com/m/news/1187736093?lang=zh_CN&edition=full","pubTime":"2021-11-27 08:43","market":"us","language":"en","title":"Amazon faces Black Friday strikes by workers across Europe<blockquote>亚马逊面临欧洲各地工人的黑色星期五罢工</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187736093","media":"CNN","summary":"Amazon(AMZN)is facing strikes by warehouse workers and delivery drivers across Europe as its busiest","content":"<p>Amazon(AMZN)is facing strikes by warehouse workers and delivery drivers across Europe as its busiest weekend of the year begins.</p><p><blockquote>随着一年中最繁忙的周末开始，亚马逊（AMZN）正面临欧洲各地仓库工人和送货司机的罢工。</blockquote></p><p> Labor unions in Germany, Italy and France are calling for the company to pay its workers fairly and respect their right to join unions. The strikes have been called to coincide with Amazon's annual Black Friday event, which kicks off a four-day shopping bonanza that culminates in Cyber Monday.</p><p><blockquote>德国、意大利和法国的工会呼吁该公司公平支付工人工资，并尊重他们加入工会的权利。此次罢工恰逢亚马逊一年一度的黑色星期五活动，该活动拉开了为期四天的购物热潮的序幕，并在网络星期一达到高潮。</blockquote></p><p> The action is part of a wider global protest organized by a group called Make Amazon Pay. The coalition of unions, environmentalists and tax campaigners has called for protests in22 countries around the world, including the United States, Canada, Brazil, and the United Kingdom.</p><p><blockquote>这一行动是由一个名为“让亚马逊支付”的组织组织的更广泛的全球抗议活动的一部分。工会、环保主义者和税收活动家联盟呼吁在全球22个国家举行抗议活动，包括美国、加拿大、巴西和英国。</blockquote></p><p> The international coalition is also demanding that Amazon \"pays its fair share of taxes and commits to real environmental sustainability.\"</p><p><blockquote>国际联盟还要求亚马逊“缴纳公平份额的税款，并致力于真正的环境可持续性。”</blockquote></p><p> An Amazon spokesperson said that the groups represented a variety of interests, and while the company was \"not perfect in any area\" it was taking its role and impact seriously.\"</p><p><blockquote>亚马逊发言人表示，这些团体代表了多种利益，虽然该公司“在任何领域都不完美”，但它正在认真对待自己的角色和影响。”</blockquote></p><p> We are inventing and investing significantly in all these areas, playing a significant role in addressing climate change with the Climate Pledge commitment to be net zero carbon by 2040, continuing to offer competitive wages and great benefits, and inventing new ways to keep our employees safe and healthy in our operations network, to name just a few,\" the spokesperson added.</p><p><blockquote>我们正在所有这些领域进行大量发明和投资，通过气候承诺到2040年实现净零碳，在应对气候变化方面发挥着重要作用，继续提供有竞争力的工资和丰厚的福利，并发明新的方法来保护我们的员工仅举几例，在我们的运营网络中保持安全和健康，”该发言人补充道。</blockquote></p><p> Some of its workers are not convinced.</p><p><blockquote>它的一些工人并不相信。</blockquote></p><p> Germany's giant Verdi union organized a strike of warehouse workers to coincide with the launch in Berlin of \"Amazon Workers against Surveillance,\" a group protesting the company's \"use of apps, hand scanners, browser tools and cameras to surveil its workforce 24/7.\"</p><p><blockquote>德国巨头威尔第工会组织了一次仓库工人罢工，恰逢“亚马逊工人反对监控”在柏林发起，该组织抗议该公司“使用应用程序、手持扫描仪、浏览器工具和摄像头全天候监控其员工”。</blockquote></p><p> \"Working almost anywhere at Amazon is stressful and hazardous to one's health,\" the group said in a statement on its website.</p><p><blockquote>该组织在其网站上的一份声明中表示：“在亚马逊几乎任何地方工作都充满压力，而且对健康有害。”</blockquote></p><p> In Italy, workers are planning to blockade warehouses and trucks at all Amazon centers across the country, and thousands of drivers are set to strike on Friday.</p><p><blockquote>在意大利，工人们正计划封锁全国所有亚马逊中心的仓库和卡车，数千名司机将于周五举行罢工。</blockquote></p><p> Warehouse workers are also striking in France, including at a logistics center in Lille, in support of demands for wage increases and bonuses, and an end to compulsory overtime.</p><p><blockquote>法国的仓库工人也在罢工，包括里尔的一个物流中心，以支持增加工资和奖金以及结束强制加班的要求。</blockquote></p><p> They told CNN that Amazon has asked employees to work on all four Saturdays during December, in addition to their usual hours. For this overtime, they would get a bonus of €120 euros ($136) subject to certain conditions, the workers said.</p><p><blockquote>他们告诉CNN，亚马逊要求员工除了正常工作时间外，在12月的所有四个周六都工作。工人们说，在某些条件下，他们将获得120欧元（136美元）的奖金。</blockquote></p><p> It's not clear how disruptive the strikes will be for Amazon, but this holiday shopping season is proving tough for retailers trying to satisfy strongconsumer demandin the face of supply chain disruptions, and shortages of workers and some goods.</p><p><blockquote>目前尚不清楚罢工对亚马逊的破坏性有多大，但事实证明，面对供应链中断、工人和某些商品短缺，这个假日购物季对于试图满足强劲消费者需求的零售商来说是艰难的。</blockquote></p><p> Make Amazon Pay was launched a year ago after 50 organizations held strikes and protests in 16 countries around the world, the coalition said.</p><p><blockquote>该联盟表示，一年前，在全球16个国家的50个组织举行罢工和抗议活动后，Make Amazon Pay推出。</blockquote></p><p> \"Today's actions show the scale of resistance to Amazon's exploitation at every link in its chain of abuse,\" said Casper Gelderblom, a coordinator of the group.</p><p><blockquote>该组织协调员卡斯珀·格尔德布洛姆(Casper Gelderblom)表示：“今天的行动显示了亚马逊滥用链各个环节对剥削的抵制程度。”</blockquote></p><p> \"Workers throughout the supply chain are demanding what's rightfully theirs when even Jeff Bezos admits their labor paid for his recent joy ride to space,\" he added.</p><p><blockquote>他补充道：“当杰夫·贝索斯也承认他们的劳动为他最近的太空之旅付出了代价时，整个供应链的工人都在要求理应属于他们的东西。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon faces Black Friday strikes by workers across Europe<blockquote>亚马逊面临欧洲各地工人的黑色星期五罢工</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon faces Black Friday strikes by workers across Europe<blockquote>亚马逊面临欧洲各地工人的黑色星期五罢工</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">CNN</strong><span class=\"h-time small\">2021-11-27 08:43</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Amazon(AMZN)is facing strikes by warehouse workers and delivery drivers across Europe as its busiest weekend of the year begins.</p><p><blockquote>随着一年中最繁忙的周末开始，亚马逊（AMZN）正面临欧洲各地仓库工人和送货司机的罢工。</blockquote></p><p> Labor unions in Germany, Italy and France are calling for the company to pay its workers fairly and respect their right to join unions. The strikes have been called to coincide with Amazon's annual Black Friday event, which kicks off a four-day shopping bonanza that culminates in Cyber Monday.</p><p><blockquote>德国、意大利和法国的工会呼吁该公司公平支付工人工资，并尊重他们加入工会的权利。此次罢工恰逢亚马逊一年一度的黑色星期五活动，该活动拉开了为期四天的购物热潮的序幕，并在网络星期一达到高潮。</blockquote></p><p> The action is part of a wider global protest organized by a group called Make Amazon Pay. The coalition of unions, environmentalists and tax campaigners has called for protests in22 countries around the world, including the United States, Canada, Brazil, and the United Kingdom.</p><p><blockquote>这一行动是由一个名为“让亚马逊支付”的组织组织的更广泛的全球抗议活动的一部分。工会、环保主义者和税收活动家联盟呼吁在全球22个国家举行抗议活动，包括美国、加拿大、巴西和英国。</blockquote></p><p> The international coalition is also demanding that Amazon \"pays its fair share of taxes and commits to real environmental sustainability.\"</p><p><blockquote>国际联盟还要求亚马逊“缴纳公平份额的税款，并致力于真正的环境可持续性。”</blockquote></p><p> An Amazon spokesperson said that the groups represented a variety of interests, and while the company was \"not perfect in any area\" it was taking its role and impact seriously.\"</p><p><blockquote>亚马逊发言人表示，这些团体代表了多种利益，虽然该公司“在任何领域都不完美”，但它正在认真对待自己的角色和影响。”</blockquote></p><p> We are inventing and investing significantly in all these areas, playing a significant role in addressing climate change with the Climate Pledge commitment to be net zero carbon by 2040, continuing to offer competitive wages and great benefits, and inventing new ways to keep our employees safe and healthy in our operations network, to name just a few,\" the spokesperson added.</p><p><blockquote>我们正在所有这些领域进行大量发明和投资，通过气候承诺到2040年实现净零碳，在应对气候变化方面发挥着重要作用，继续提供有竞争力的工资和丰厚的福利，并发明新的方法来保护我们的员工仅举几例，在我们的运营网络中保持安全和健康，”该发言人补充道。</blockquote></p><p> Some of its workers are not convinced.</p><p><blockquote>它的一些工人并不相信。</blockquote></p><p> Germany's giant Verdi union organized a strike of warehouse workers to coincide with the launch in Berlin of \"Amazon Workers against Surveillance,\" a group protesting the company's \"use of apps, hand scanners, browser tools and cameras to surveil its workforce 24/7.\"</p><p><blockquote>德国巨头威尔第工会组织了一次仓库工人罢工，恰逢“亚马逊工人反对监控”在柏林发起，该组织抗议该公司“使用应用程序、手持扫描仪、浏览器工具和摄像头全天候监控其员工”。</blockquote></p><p> \"Working almost anywhere at Amazon is stressful and hazardous to one's health,\" the group said in a statement on its website.</p><p><blockquote>该组织在其网站上的一份声明中表示：“在亚马逊几乎任何地方工作都充满压力，而且对健康有害。”</blockquote></p><p> In Italy, workers are planning to blockade warehouses and trucks at all Amazon centers across the country, and thousands of drivers are set to strike on Friday.</p><p><blockquote>在意大利，工人们正计划封锁全国所有亚马逊中心的仓库和卡车，数千名司机将于周五举行罢工。</blockquote></p><p> Warehouse workers are also striking in France, including at a logistics center in Lille, in support of demands for wage increases and bonuses, and an end to compulsory overtime.</p><p><blockquote>法国的仓库工人也在罢工，包括里尔的一个物流中心，以支持增加工资和奖金以及结束强制加班的要求。</blockquote></p><p> They told CNN that Amazon has asked employees to work on all four Saturdays during December, in addition to their usual hours. For this overtime, they would get a bonus of €120 euros ($136) subject to certain conditions, the workers said.</p><p><blockquote>他们告诉CNN，亚马逊要求员工除了正常工作时间外，在12月的所有四个周六都工作。工人们说，在某些条件下，他们将获得120欧元（136美元）的奖金。</blockquote></p><p> It's not clear how disruptive the strikes will be for Amazon, but this holiday shopping season is proving tough for retailers trying to satisfy strongconsumer demandin the face of supply chain disruptions, and shortages of workers and some goods.</p><p><blockquote>目前尚不清楚罢工对亚马逊的破坏性有多大，但事实证明，面对供应链中断、工人和某些商品短缺，这个假日购物季对于试图满足强劲消费者需求的零售商来说是艰难的。</blockquote></p><p> Make Amazon Pay was launched a year ago after 50 organizations held strikes and protests in 16 countries around the world, the coalition said.</p><p><blockquote>该联盟表示，一年前，在全球16个国家的50个组织举行罢工和抗议活动后，Make Amazon Pay推出。</blockquote></p><p> \"Today's actions show the scale of resistance to Amazon's exploitation at every link in its chain of abuse,\" said Casper Gelderblom, a coordinator of the group.</p><p><blockquote>该组织协调员卡斯珀·格尔德布洛姆(Casper Gelderblom)表示：“今天的行动显示了亚马逊滥用链各个环节对剥削的抵制程度。”</blockquote></p><p> \"Workers throughout the supply chain are demanding what's rightfully theirs when even Jeff Bezos admits their labor paid for his recent joy ride to space,\" he added.</p><p><blockquote>他补充道：“当杰夫·贝索斯也承认他们的劳动为他最近的太空之旅付出了代价时，整个供应链的工人都在要求理应属于他们的东西。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://edition.cnn.com/2021/11/26/tech/amazon-workers-strike-shopping-holiday/index.html\">CNN</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://edition.cnn.com/2021/11/26/tech/amazon-workers-strike-shopping-holiday/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187736093","content_text":"Amazon(AMZN)is facing strikes by warehouse workers and delivery drivers across Europe as its busiest weekend of the year begins.\nLabor unions in Germany, Italy and France are calling for the company to pay its workers fairly and respect their right to join unions. The strikes have been called to coincide with Amazon's annual Black Friday event, which kicks off a four-day shopping bonanza that culminates in Cyber Monday.\nThe action is part of a wider global protest organized by a group called Make Amazon Pay. The coalition of unions, environmentalists and tax campaigners has called for protests in22 countries around the world, including the United States, Canada, Brazil, and the United Kingdom.\nThe international coalition is also demanding that Amazon \"pays its fair share of taxes and commits to real environmental sustainability.\"\nAn Amazon spokesperson said that the groups represented a variety of interests, and while the company was \"not perfect in any area\" it was taking its role and impact seriously.\"\nWe are inventing and investing significantly in all these areas, playing a significant role in addressing climate change with the Climate Pledge commitment to be net zero carbon by 2040, continuing to offer competitive wages and great benefits, and inventing new ways to keep our employees safe and healthy in our operations network, to name just a few,\" the spokesperson added.\nSome of its workers are not convinced.\nGermany's giant Verdi union organized a strike of warehouse workers to coincide with the launch in Berlin of \"Amazon Workers against Surveillance,\" a group protesting the company's \"use of apps, hand scanners, browser tools and cameras to surveil its workforce 24/7.\"\n\"Working almost anywhere at Amazon is stressful and hazardous to one's health,\" the group said in a statement on its website.\nIn Italy, workers are planning to blockade warehouses and trucks at all Amazon centers across the country, and thousands of drivers are set to strike on Friday.\nWarehouse workers are also striking in France, including at a logistics center in Lille, in support of demands for wage increases and bonuses, and an end to compulsory overtime.\nThey told CNN that Amazon has asked employees to work on all four Saturdays during December, in addition to their usual hours. For this overtime, they would get a bonus of €120 euros ($136) subject to certain conditions, the workers said.\nIt's not clear how disruptive the strikes will be for Amazon, but this holiday shopping season is proving tough for retailers trying to satisfy strongconsumer demandin the face of supply chain disruptions, and shortages of workers and some goods.\nMake Amazon Pay was launched a year ago after 50 organizations held strikes and protests in 16 countries around the world, the coalition said.\n\"Today's actions show the scale of resistance to Amazon's exploitation at every link in its chain of abuse,\" said Casper Gelderblom, a coordinator of the group.\n\"Workers throughout the supply chain are demanding what's rightfully theirs when even Jeff Bezos admits their labor paid for his recent joy ride to space,\" he added.","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":832,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877046602,"gmtCreate":1637850335798,"gmtModify":1637850386437,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877046602","repostId":"1143924299","repostType":4,"repost":{"id":"1143924299","kind":"news","pubTimestamp":1637846658,"share":"https://www.laohu8.com/m/news/1143924299?lang=zh_CN&edition=full","pubTime":"2021-11-25 21:24","market":"us","language":"en","title":"What Inflation? Small Investors Keep Piling Into Flashy Growth Stocks<blockquote>什么通货膨胀？小投资者不断涌入华丽的成长型股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1143924299","media":"WSJ","summary":"Conventional Wall Street wisdom says inflation is bad for growth and technology stocks. Many small i","content":"<p>Conventional Wall Street wisdom says inflation is bad for growth and technology stocks. Many small investors don’t care.</p><p><blockquote>华尔街的传统观点认为，通胀不利于增长股和科技股。很多小投资者不在乎。</blockquote></p><p> Individual investors continue to stampede into shares of growth companies, the types of buzzy stocks that have enjoyed explosive price gains this year. Advanced Micro Devices Inc.,&nbsp;Nvidia Corp. and Apple Inc. are the three stocks most purchased this month by individual investors, according to VandaTrack, a Vanda Research flow tracker that measures net purchases.</p><p><blockquote>个人投资者继续涌入成长型公司的股票，这些热门股票今年价格出现了爆炸性上涨。根据衡量净购买量的Vanda Research流量跟踪机构VandaTrack的数据，Advanced Micro Devices Inc.、Nvidia Corp.和苹果公司是本月个人投资者购买最多的三只股票。</blockquote></p><p> Growth stocks are typically companies—often tech firms—that are expected to deliver faster-than-average profit growth in the future. They tend to flourish in a low-rate environment, including over the past year and a half. Investors are typically willing to pay higher prices for such companies when they don’t see many alternatives for making sizable profits.</p><p><blockquote>成长型股票通常是预计未来利润增长快于平均水平的公司（通常是科技公司）。它们往往在低利率环境中蓬勃发展，包括在过去一年半的时间里。当投资者看不到许多赚取可观利润的替代方案时，他们通常愿意为此类公司支付更高的价格。</blockquote></p><p> For example, 18 of the stocks that are most favored by individual investors, including the chip makers AMD and Nvidia, trade on average at nearly 13 times their trailing 12-month sales, according to an analysis by Dow Jones Market Data. Stocks in the S&amp;P 500 trade at an average of three times their sales.</p><p><blockquote>例如，根据道琼斯市场数据的分析，包括芯片制造商AMD和英伟达在内的18只最受个人投资者青睐的股票的平均交易价格是其过去12个月销售额的近13倍。标普500股票的平均交易价格是其销售额的三倍。</blockquote></p><p> But mounting inflation can be troublesome for growth stocks. That is because inflation brings the prospect of higher interest rates and higher bond yields, making the future cash flows of growth stocks less attractive. Traders, in turn, typically shuffle their portfolios to include other investments that stand to benefit from rising rates.</p><p><blockquote>但通胀上升可能会给成长型股票带来麻烦。这是因为通胀带来了利率上升和债券收益率上升的前景，使得成长型股票的未来现金流吸引力下降。反过来，交易者通常会调整他们的投资组合，纳入其他将从利率上升中受益的投资。</blockquote></p><p> A government report this month showed that the consumer-price index jumped 6.2% in October from a year earlier, climbing atthe fastest pace in three decades. Fund-flow tracker EPFR, whose data captures mostly institutional investor behavior, estimates that investors responded by yanking more than $2 billion out of U.S. tech-focused mutual and exchange-traded funds in the two weeks ended Nov. 17. That marks the worst stretch since a two-week period ended in early January 2019.</p><p><blockquote>本月的一份政府报告显示，10月份消费者价格指数同比上涨6.2%，以三十年来最快的速度攀升。资金流追踪公司EPFR的数据主要捕捉机构投资者的行为，该公司估计，截至11月17日的两周内，投资者从美国以科技为重点的共同基金和交易所交易基金中撤出了超过20亿美元。这是自2019年1月初结束的两周以来最糟糕的一段时间。</blockquote></p><p> At the same time, institutional investors are pumping money into more value-oriented sectors, such as consumer goods, healthcare and utilities, EPFR data show. Those industries tend to trade at lower valuations and tend to be more defensive moves for investors during times of heightened uncertainty.</p><p><blockquote>EPFR数据显示，与此同时，机构投资者正在向消费品、医疗保健和公用事业等更具价值导向的行业注入资金。这些行业的估值往往较低，在不确定性加剧的时期，投资者往往会采取更具防御性的举措。</blockquote></p><p> Greg Hahn, chief investment officer of Indianapolis-based Winthrop Capital Management, said his team has been paring back exposure to large-cap technology stocks.</p><p><blockquote>总部位于印第安纳波利斯的温思罗普资本管理公司首席投资官格雷格·哈恩表示，他的团队一直在削减对大型科技股的投资。</blockquote></p><p> “We’re shifting out of growth,” Mr. Hahn said. Instead, the firm is focused on finding quality companies that have reasonable valuations and strong balance sheets—ones that are “sustainable in a potentially rough next market cycle,” he said.</p><p><blockquote>“我们正在摆脱增长，”哈恩先生说。相反，该公司专注于寻找估值合理、资产负债表强劲的优质公司——这些公司“在可能艰难的下一个市场周期中可持续发展”，他表示。</blockquote></p><p> Recently, Mr. Hahn said, he has added exposure to a company that manufactures engines and generators and a pharmaceutical company that produces medicines and other products for animals.</p><p><blockquote>哈恩先生说，最近，他增加了对一家制造发动机和发电机的公司以及一家为动物生产药品和其他产品的制药公司的投资。</blockquote></p><p> To be sure, U.S. stocks are still hovering near records, bond yields remain historically low and&nbsp;an earlier rally in gold prices&nbsp;has subsided. That suggests that inflation fears haven’t yet spurred many professional investors to entirely upend their playbooks. Some 61% of fund managers surveyed this month believe inflation is transitory, according to Bank of America Global Research.</p><p><blockquote>可以肯定的是，美国股市仍在纪录附近徘徊，债券收益率仍处于历史低位，金价早些时候的涨势已经消退。这表明通胀担忧尚未刺激许多专业投资者完全颠覆他们的策略。根据美国银行全球研究部的数据，本月接受调查的约61%的基金经理认为通胀是暂时的。</blockquote></p><p> Still, the recent divergence in strategy between professional and individual investors is the latest example of&nbsp;the unusual dynamics that have played out in financial markets&nbsp;this year. Repeatedly, small investors&nbsp;have upended longstanding trading strategies&nbsp;by sending stocks such asGameStopCorp.andHertz Global HoldingsInc.HTZ11.06%soaring, with little regard for the companies’ underlying value. Some rely on classic momentum investing—a strategy of buying assets simply because they are rising.</p><p><blockquote>尽管如此，最近专业投资者和个人投资者之间的策略分歧是今年金融市场异常动态的最新例子。小投资者多次颠覆了长期的交易策略，推动GameStopCorp.和Hertz Global HoldingsInc.等股票飙升，而很少考虑这些公司的潜在价值。有些人依赖经典的动量投资——一种仅仅因为资产正在上涨就购买资产的策略。</blockquote></p><p> It isn’t uncommon for stocks favored by individual investors to be volatile. But those stocks can pay off too: AMD and Nvidia are each up 28% or more month-to-date, while Apple has climbed 8.1%. That compares with a 2.1% rise for the S&amp;P 500.</p><p><blockquote>个人投资者青睐的股票波动并不罕见。但这些股票也可以获得回报：AMD和Nvidia本月迄今均上涨了28%或更多，而苹果则上涨了8.1%。相比之下，标普500的涨幅为2.1%。</blockquote></p><p> “The lesson we’ve learned over the past 12 to 18 months…is that IPOs, fiscal stimulus and other micro [events] are much bigger drivers for retail investor behavior” than inflation readings, said Viraj Patel, global macro strategist at Vanda Research. “We’ve never woken up the day after the CPI and seen huge selling from retail investors.”</p><p><blockquote>Vanda Research全球宏观策略师Viraj Patel表示，“我们在过去12至18个月中吸取的教训……是，IPO、财政刺激和其他微观[事件]是散户投资者行为的更大驱动因素”。“我们从来没有在CPI公布后的第二天醒来，看到散户投资者大量抛售。”</blockquote></p><p> Matt Delao, a 28-year-old individual investor from California, said he has followed data on inflation and supply-chain snarls this year. But he said his trading strategy has focused mostly on screening for stocks that appear priced for a significant move. Recently, he has traded options for AMD and bitcoin-mining companyRiot Blockchain&nbsp;Inc.</p><p><blockquote>来自加州的28岁个人投资者马特·德劳(Matt Delao)表示，他今年一直在关注通胀和供应链混乱的数据。但他表示，他的交易策略主要集中在筛选那些定价似乎会出现重大波动的股票。最近，他交易了AMD和比特币矿业公司Riot Blockchain Inc.的期权。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Inflation? Small Investors Keep Piling Into Flashy Growth Stocks<blockquote>什么通货膨胀？小投资者不断涌入华丽的成长型股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Inflation? Small Investors Keep Piling Into Flashy Growth Stocks<blockquote>什么通货膨胀？小投资者不断涌入华丽的成长型股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">WSJ</strong><span class=\"h-time small\">2021-11-25 21:24</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Conventional Wall Street wisdom says inflation is bad for growth and technology stocks. Many small investors don’t care.</p><p><blockquote>华尔街的传统观点认为，通胀不利于增长股和科技股。很多小投资者不在乎。</blockquote></p><p> Individual investors continue to stampede into shares of growth companies, the types of buzzy stocks that have enjoyed explosive price gains this year. Advanced Micro Devices Inc.,&nbsp;Nvidia Corp. and Apple Inc. are the three stocks most purchased this month by individual investors, according to VandaTrack, a Vanda Research flow tracker that measures net purchases.</p><p><blockquote>个人投资者继续涌入成长型公司的股票，这些热门股票今年价格出现了爆炸性上涨。根据衡量净购买量的Vanda Research流量跟踪机构VandaTrack的数据，Advanced Micro Devices Inc.、Nvidia Corp.和苹果公司是本月个人投资者购买最多的三只股票。</blockquote></p><p> Growth stocks are typically companies—often tech firms—that are expected to deliver faster-than-average profit growth in the future. They tend to flourish in a low-rate environment, including over the past year and a half. Investors are typically willing to pay higher prices for such companies when they don’t see many alternatives for making sizable profits.</p><p><blockquote>成长型股票通常是预计未来利润增长快于平均水平的公司（通常是科技公司）。它们往往在低利率环境中蓬勃发展，包括在过去一年半的时间里。当投资者看不到许多赚取可观利润的替代方案时，他们通常愿意为此类公司支付更高的价格。</blockquote></p><p> For example, 18 of the stocks that are most favored by individual investors, including the chip makers AMD and Nvidia, trade on average at nearly 13 times their trailing 12-month sales, according to an analysis by Dow Jones Market Data. Stocks in the S&amp;P 500 trade at an average of three times their sales.</p><p><blockquote>例如，根据道琼斯市场数据的分析，包括芯片制造商AMD和英伟达在内的18只最受个人投资者青睐的股票的平均交易价格是其过去12个月销售额的近13倍。标普500股票的平均交易价格是其销售额的三倍。</blockquote></p><p> But mounting inflation can be troublesome for growth stocks. That is because inflation brings the prospect of higher interest rates and higher bond yields, making the future cash flows of growth stocks less attractive. Traders, in turn, typically shuffle their portfolios to include other investments that stand to benefit from rising rates.</p><p><blockquote>但通胀上升可能会给成长型股票带来麻烦。这是因为通胀带来了利率上升和债券收益率上升的前景，使得成长型股票的未来现金流吸引力下降。反过来，交易者通常会调整他们的投资组合，纳入其他将从利率上升中受益的投资。</blockquote></p><p> A government report this month showed that the consumer-price index jumped 6.2% in October from a year earlier, climbing atthe fastest pace in three decades. Fund-flow tracker EPFR, whose data captures mostly institutional investor behavior, estimates that investors responded by yanking more than $2 billion out of U.S. tech-focused mutual and exchange-traded funds in the two weeks ended Nov. 17. That marks the worst stretch since a two-week period ended in early January 2019.</p><p><blockquote>本月的一份政府报告显示，10月份消费者价格指数同比上涨6.2%，以三十年来最快的速度攀升。资金流追踪公司EPFR的数据主要捕捉机构投资者的行为，该公司估计，截至11月17日的两周内，投资者从美国以科技为重点的共同基金和交易所交易基金中撤出了超过20亿美元。这是自2019年1月初结束的两周以来最糟糕的一段时间。</blockquote></p><p> At the same time, institutional investors are pumping money into more value-oriented sectors, such as consumer goods, healthcare and utilities, EPFR data show. Those industries tend to trade at lower valuations and tend to be more defensive moves for investors during times of heightened uncertainty.</p><p><blockquote>EPFR数据显示，与此同时，机构投资者正在向消费品、医疗保健和公用事业等更具价值导向的行业注入资金。这些行业的估值往往较低，在不确定性加剧的时期，投资者往往会采取更具防御性的举措。</blockquote></p><p> Greg Hahn, chief investment officer of Indianapolis-based Winthrop Capital Management, said his team has been paring back exposure to large-cap technology stocks.</p><p><blockquote>总部位于印第安纳波利斯的温思罗普资本管理公司首席投资官格雷格·哈恩表示，他的团队一直在削减对大型科技股的投资。</blockquote></p><p> “We’re shifting out of growth,” Mr. Hahn said. Instead, the firm is focused on finding quality companies that have reasonable valuations and strong balance sheets—ones that are “sustainable in a potentially rough next market cycle,” he said.</p><p><blockquote>“我们正在摆脱增长，”哈恩先生说。相反，该公司专注于寻找估值合理、资产负债表强劲的优质公司——这些公司“在可能艰难的下一个市场周期中可持续发展”，他表示。</blockquote></p><p> Recently, Mr. Hahn said, he has added exposure to a company that manufactures engines and generators and a pharmaceutical company that produces medicines and other products for animals.</p><p><blockquote>哈恩先生说，最近，他增加了对一家制造发动机和发电机的公司以及一家为动物生产药品和其他产品的制药公司的投资。</blockquote></p><p> To be sure, U.S. stocks are still hovering near records, bond yields remain historically low and&nbsp;an earlier rally in gold prices&nbsp;has subsided. That suggests that inflation fears haven’t yet spurred many professional investors to entirely upend their playbooks. Some 61% of fund managers surveyed this month believe inflation is transitory, according to Bank of America Global Research.</p><p><blockquote>可以肯定的是，美国股市仍在纪录附近徘徊，债券收益率仍处于历史低位，金价早些时候的涨势已经消退。这表明通胀担忧尚未刺激许多专业投资者完全颠覆他们的策略。根据美国银行全球研究部的数据，本月接受调查的约61%的基金经理认为通胀是暂时的。</blockquote></p><p> Still, the recent divergence in strategy between professional and individual investors is the latest example of&nbsp;the unusual dynamics that have played out in financial markets&nbsp;this year. Repeatedly, small investors&nbsp;have upended longstanding trading strategies&nbsp;by sending stocks such asGameStopCorp.andHertz Global HoldingsInc.HTZ11.06%soaring, with little regard for the companies’ underlying value. Some rely on classic momentum investing—a strategy of buying assets simply because they are rising.</p><p><blockquote>尽管如此，最近专业投资者和个人投资者之间的策略分歧是今年金融市场异常动态的最新例子。小投资者多次颠覆了长期的交易策略，推动GameStopCorp.和Hertz Global HoldingsInc.等股票飙升，而很少考虑这些公司的潜在价值。有些人依赖经典的动量投资——一种仅仅因为资产正在上涨就购买资产的策略。</blockquote></p><p> It isn’t uncommon for stocks favored by individual investors to be volatile. But those stocks can pay off too: AMD and Nvidia are each up 28% or more month-to-date, while Apple has climbed 8.1%. That compares with a 2.1% rise for the S&amp;P 500.</p><p><blockquote>个人投资者青睐的股票波动并不罕见。但这些股票也可以获得回报：AMD和Nvidia本月迄今均上涨了28%或更多，而苹果则上涨了8.1%。相比之下，标普500的涨幅为2.1%。</blockquote></p><p> “The lesson we’ve learned over the past 12 to 18 months…is that IPOs, fiscal stimulus and other micro [events] are much bigger drivers for retail investor behavior” than inflation readings, said Viraj Patel, global macro strategist at Vanda Research. “We’ve never woken up the day after the CPI and seen huge selling from retail investors.”</p><p><blockquote>Vanda Research全球宏观策略师Viraj Patel表示，“我们在过去12至18个月中吸取的教训……是，IPO、财政刺激和其他微观[事件]是散户投资者行为的更大驱动因素”。“我们从来没有在CPI公布后的第二天醒来，看到散户投资者大量抛售。”</blockquote></p><p> Matt Delao, a 28-year-old individual investor from California, said he has followed data on inflation and supply-chain snarls this year. But he said his trading strategy has focused mostly on screening for stocks that appear priced for a significant move. Recently, he has traded options for AMD and bitcoin-mining companyRiot Blockchain&nbsp;Inc.</p><p><blockquote>来自加州的28岁个人投资者马特·德劳(Matt Delao)表示，他今年一直在关注通胀和供应链混乱的数据。但他表示，他的交易策略主要集中在筛选那些定价似乎会出现重大波动的股票。最近，他交易了AMD和比特币矿业公司Riot Blockchain Inc.的期权。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/what-inflation-small-investors-keep-piling-into-flashy-growth-stocks-11637836200?siteid=yhoof2\">WSJ</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","NVDA":"英伟达","AAPL":"苹果"},"source_url":"https://www.wsj.com/articles/what-inflation-small-investors-keep-piling-into-flashy-growth-stocks-11637836200?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143924299","content_text":"Conventional Wall Street wisdom says inflation is bad for growth and technology stocks. Many small investors don’t care.\nIndividual investors continue to stampede into shares of growth companies, the types of buzzy stocks that have enjoyed explosive price gains this year. Advanced Micro Devices Inc., Nvidia Corp. and Apple Inc. are the three stocks most purchased this month by individual investors, according to VandaTrack, a Vanda Research flow tracker that measures net purchases.\nGrowth stocks are typically companies—often tech firms—that are expected to deliver faster-than-average profit growth in the future. They tend to flourish in a low-rate environment, including over the past year and a half. Investors are typically willing to pay higher prices for such companies when they don’t see many alternatives for making sizable profits.\nFor example, 18 of the stocks that are most favored by individual investors, including the chip makers AMD and Nvidia, trade on average at nearly 13 times their trailing 12-month sales, according to an analysis by Dow Jones Market Data. Stocks in the S&P 500 trade at an average of three times their sales.\nBut mounting inflation can be troublesome for growth stocks. That is because inflation brings the prospect of higher interest rates and higher bond yields, making the future cash flows of growth stocks less attractive. Traders, in turn, typically shuffle their portfolios to include other investments that stand to benefit from rising rates.\nA government report this month showed that the consumer-price index jumped 6.2% in October from a year earlier, climbing atthe fastest pace in three decades. Fund-flow tracker EPFR, whose data captures mostly institutional investor behavior, estimates that investors responded by yanking more than $2 billion out of U.S. tech-focused mutual and exchange-traded funds in the two weeks ended Nov. 17. That marks the worst stretch since a two-week period ended in early January 2019.\nAt the same time, institutional investors are pumping money into more value-oriented sectors, such as consumer goods, healthcare and utilities, EPFR data show. Those industries tend to trade at lower valuations and tend to be more defensive moves for investors during times of heightened uncertainty.\nGreg Hahn, chief investment officer of Indianapolis-based Winthrop Capital Management, said his team has been paring back exposure to large-cap technology stocks.\n“We’re shifting out of growth,” Mr. Hahn said. Instead, the firm is focused on finding quality companies that have reasonable valuations and strong balance sheets—ones that are “sustainable in a potentially rough next market cycle,” he said.\nRecently, Mr. Hahn said, he has added exposure to a company that manufactures engines and generators and a pharmaceutical company that produces medicines and other products for animals.\nTo be sure, U.S. stocks are still hovering near records, bond yields remain historically low and an earlier rally in gold prices has subsided. That suggests that inflation fears haven’t yet spurred many professional investors to entirely upend their playbooks. Some 61% of fund managers surveyed this month believe inflation is transitory, according to Bank of America Global Research.\nStill, the recent divergence in strategy between professional and individual investors is the latest example of the unusual dynamics that have played out in financial markets this year. Repeatedly, small investors have upended longstanding trading strategies by sending stocks such asGameStopCorp.andHertz Global HoldingsInc.HTZ11.06%soaring, with little regard for the companies’ underlying value. Some rely on classic momentum investing—a strategy of buying assets simply because they are rising.\nIt isn’t uncommon for stocks favored by individual investors to be volatile. But those stocks can pay off too: AMD and Nvidia are each up 28% or more month-to-date, while Apple has climbed 8.1%. That compares with a 2.1% rise for the S&P 500.\n“The lesson we’ve learned over the past 12 to 18 months…is that IPOs, fiscal stimulus and other micro [events] are much bigger drivers for retail investor behavior” than inflation readings, said Viraj Patel, global macro strategist at Vanda Research. “We’ve never woken up the day after the CPI and seen huge selling from retail investors.”\nMatt Delao, a 28-year-old individual investor from California, said he has followed data on inflation and supply-chain snarls this year. But he said his trading strategy has focused mostly on screening for stocks that appear priced for a significant move. Recently, he has traded options for AMD and bitcoin-mining companyRiot Blockchain Inc.","news_type":1,"symbols_score_info":{"AMD":0.9,"AAPL":0.9,"NVDA":0.9}},"isVote":1,"tweetType":1,"viewCount":796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874112818,"gmtCreate":1637742704688,"gmtModify":1637742704760,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3565930395680990","idStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874112818","repostId":"1127565646","repostType":4,"isVote":1,"tweetType":1,"viewCount":914,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":897299671,"gmtCreate":1628919244593,"gmtModify":1631893764054,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/897299671","repostId":"2159321505","repostType":4,"repost":{"id":"2159321505","kind":"highlight","pubTimestamp":1628911811,"share":"https://www.laohu8.com/m/news/2159321505?lang=zh_CN&edition=full","pubTime":"2021-08-14 11:30","market":"us","language":"en","title":"Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting<blockquote>特斯拉寻求缩短董事会成员任期，并在十月股东大会上做出其他改变</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2159321505","media":"MarketWatch","summary":"Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. ","content":"<p>Board members would serve for two years rather than three</p><p><blockquote>董事会成员的任期为两年，而不是三年</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/abc701f141f0c0044cabe912e510fe2e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Tesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES</span></p><p><blockquote><p class=\"t-img-caption\"><span>特斯拉首席执行官Elon Musk去年在德国。玛雅·希蒂吉/盖蒂图片社</span></p></blockquote></p><p> Tesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.</p><p><blockquote>特斯拉公司在周五晚间提交的文件中表示，该公司将于10月7日在加州弗里蒙特工厂举行股东大会，该公司将提出的提案包括缩短董事任期的看涨期权。</blockquote></p><p> One of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s&nbsp;board currently has nine members who are divided into three classes in staggered three-year terms.</p><p><blockquote>其中一项建议是评级将每名董事的任期从三年减至两年。特斯拉董事会目前有九名成员，分为三类，任期三年。</blockquote></p><p> If the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the&nbsp;filing.</p><p><blockquote>然而，特斯拉在文件中表示，如果该提案获得批准，董事会将分为两个任期交错的类别，董事在两个类别之间的分布尽可能平均。</blockquote></p><p> The board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.</p><p><blockquote>自2007年以来一直在特斯拉董事会任职的风险投资家Antonio Gracias在2019年表示，今年任期结束后，他不会寻求连任，董事会成员将减少至8名。</blockquote></p><p> Tesla’s board nominated current board members James Murdoch, the youngest son of News Corp&nbsp;founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.</p><p><blockquote>特斯拉董事会提名现任董事会成员、新闻集团创始人默多克的小儿子默多克（James Murdoch）和首席执行官马斯克（Elon Musk）的哥哥马斯克（Kimbal Musk）连任二级董事，任期将于2024年届满。该公司表示，如果期限缩减获得批准，那么他们的期限将于2023年结束。</blockquote></p><p> Tesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.</p><p><blockquote>特斯拉缩短董事会成员任期是对股东提议选举每位董事会成员一年的回应。</blockquote></p><p> The two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.</p><p><blockquote>然而，特斯拉表示，两年任期“在股东的长期利益和近期责任之间取得了适当的平衡”。</blockquote></p><p> Tesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&amp;P 500 index.</p><p><blockquote>特斯拉股价在常规交易日收盘下跌0.7%后，在盘后交易中持平。该股今年已上涨1.6%，而标普500指数的涨幅约为19%。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla seeks to reduce board members’ terms, make other changes in October shareholder meeting<blockquote>特斯拉寻求缩短董事会成员任期，并在十月股东大会上做出其他改变</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla seeks to reduce board members’ terms, make other changes in October shareholder meeting<blockquote>特斯拉寻求缩短董事会成员任期，并在十月股东大会上做出其他改变</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-08-14 11:30</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Board members would serve for two years rather than three</p><p><blockquote>董事会成员的任期为两年，而不是三年</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/abc701f141f0c0044cabe912e510fe2e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Tesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES</span></p><p><blockquote><p class=\"t-img-caption\"><span>特斯拉首席执行官Elon Musk去年在德国。玛雅·希蒂吉/盖蒂图片社</span></p></blockquote></p><p> Tesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.</p><p><blockquote>特斯拉公司在周五晚间提交的文件中表示，该公司将于10月7日在加州弗里蒙特工厂举行股东大会，该公司将提出的提案包括缩短董事任期的看涨期权。</blockquote></p><p> One of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s&nbsp;board currently has nine members who are divided into three classes in staggered three-year terms.</p><p><blockquote>其中一项建议是评级将每名董事的任期从三年减至两年。特斯拉董事会目前有九名成员，分为三类，任期三年。</blockquote></p><p> If the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the&nbsp;filing.</p><p><blockquote>然而，特斯拉在文件中表示，如果该提案获得批准，董事会将分为两个任期交错的类别，董事在两个类别之间的分布尽可能平均。</blockquote></p><p> The board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.</p><p><blockquote>自2007年以来一直在特斯拉董事会任职的风险投资家Antonio Gracias在2019年表示，今年任期结束后，他不会寻求连任，董事会成员将减少至8名。</blockquote></p><p> Tesla’s board nominated current board members James Murdoch, the youngest son of News Corp&nbsp;founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.</p><p><blockquote>特斯拉董事会提名现任董事会成员、新闻集团创始人默多克的小儿子默多克（James Murdoch）和首席执行官马斯克（Elon Musk）的哥哥马斯克（Kimbal Musk）连任二级董事，任期将于2024年届满。该公司表示，如果期限缩减获得批准，那么他们的期限将于2023年结束。</blockquote></p><p> Tesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.</p><p><blockquote>特斯拉缩短董事会成员任期是对股东提议选举每位董事会成员一年的回应。</blockquote></p><p> The two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.</p><p><blockquote>然而，特斯拉表示，两年任期“在股东的长期利益和近期责任之间取得了适当的平衡”。</blockquote></p><p> Tesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&amp;P 500 index.</p><p><blockquote>特斯拉股价在常规交易日收盘下跌0.7%后，在盘后交易中持平。该股今年已上涨1.6%，而标普500指数的涨幅约为19%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/story/tesla-seeks-to-reduce-board-terms-in-october-shareholder-meeting-11628888340?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159321505","content_text":"Board members would serve for two years rather than three\nTesla CEO Elon Musk in Germany last year. MAJA HITIJ/GETTY IMAGES\nTesla Inc. set its shareholder meeting for Oct. 7 at the Fremont, Calif., factory, with a call for reducing its directors’ terms among the proposals the electric-car maker will bring to the table, the company said in filing late Friday.\nOne of the proposals calls for each director’s term to be reduced from three years to two years. Tesla’s board currently has nine members who are divided into three classes in staggered three-year terms.\nIf the proposal is approved, however, the board will be divided into two classes with staggered two-year terms, with directors distributed as equally between the classes as possible, Tesla said in the filing.\nThe board would be reduced to eight members, since Antonio Gracias, a venture capitalist who has served on the Tesla board since 2007, said in 2019 he’d not be seeking reelection when his term ends this year.\nTesla’s board nominated current board members James Murdoch, the youngest son of News Corp founder Rupert Murdoch, and Kimbal Musk, Chief Executive Elon Musk’s brother, for re-election as class II directors, with terms expiring in 2024. If the term reduction is approved, then their terms would end in 2023, the company said.\nTesla’s curtailing board member terms was a response to a shareholder proposal calling to elect each board member for one year.\nThe two-year term, however, “strikes a suitable balance to the long-term interests of and nearer-term accountability to our stockholders at this time,” Tesla said.\nTesla shares were flat in after-hours trading after ending the regular trading day down 0.7%. The stock has gained 1.6% this year, compared with gains of around 19% for the S&P 500 index.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808670110,"gmtCreate":1627578379830,"gmtModify":1633758103132,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/808670110","repostId":"1165497040","repostType":4,"isVote":1,"tweetType":1,"viewCount":539,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":604301439,"gmtCreate":1639325093032,"gmtModify":1639325093141,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/604301439","repostId":"2190719536","repostType":4,"isVote":1,"tweetType":1,"viewCount":2685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820897525,"gmtCreate":1633365842564,"gmtModify":1633365842753,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/820897525","repostId":"2172996701","repostType":4,"isVote":1,"tweetType":1,"viewCount":476,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":899357758,"gmtCreate":1628163799674,"gmtModify":1633753041855,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/899357758","repostId":"1121665544","repostType":4,"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":693069194,"gmtCreate":1639930012033,"gmtModify":1639930012195,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/693069194","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=zh_CN&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&amp;P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&amp;A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块，涨幅约为2.5%，主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨，而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&amp;A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中，<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司，溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势，本周上涨约20.7%，有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗，股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时，这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后，该公司每周上涨约25.2%，使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时，Vir Biotechnology（纳斯达克股票代码：VIR）飙升约23.7%，成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克（纽约证券交易所股票代码：GSK）合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有，<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家：<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻，再次提高了COVID-19疫苗的销售指引，因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势，<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%，创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中，两家新IPO的生物技术公司Instil Bio（纳斯达克股票代码：TIL）和Exscientia（纳斯达克股票代码：EXAI）脱颖而出，尽管它们在华尔街获得了良好的评级，但分别下跌了19.3%和约13.5%。与此同时，处方药比价平台运营商GoodRx Holdings（纳斯达克股票代码：GDRX）股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的，<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>，暴跌约13.1%，受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics（纳斯达克股票代码：ALLO）在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋，其中包括Cathie Wood的Ark Investment Management，该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列，辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-19 11:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The healthcare stocks in the S&amp;P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&amp;A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块，涨幅约为2.5%，主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨，而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&amp;A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中，<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司，溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势，本周上涨约20.7%，有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗，股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时，这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后，该公司每周上涨约25.2%，使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时，Vir Biotechnology（纳斯达克股票代码：VIR）飙升约23.7%，成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克（纽约证券交易所股票代码：GSK）合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有，<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家：<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻，再次提高了COVID-19疫苗的销售指引，因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势，<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%，创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中，两家新IPO的生物技术公司Instil Bio（纳斯达克股票代码：TIL）和Exscientia（纳斯达克股票代码：EXAI）脱颖而出，尽管它们在华尔街获得了良好的评级，但分别下跌了19.3%和约13.5%。与此同时，处方药比价平台运营商GoodRx Holdings（纳斯达克股票代码：GDRX）股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的，<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>，暴跌约13.1%，受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics（纳斯达克股票代码：ALLO）在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋，其中包括Cathie Wood的Ark Investment Management，该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","ORCL":"甲骨文","PFE":"辉瑞","ARNA":"阿里那","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","CERN":"美国塞纳"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals  dominated with a ~83.8% rise after Pfizer  agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner  also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle  for the electronic-medical-records company.\nVaccine developer, Novavax  jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical  posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences  added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"PFE":0.9,"ORCL":0.9,"CERN":0.9,"ARNA":0.9}},"isVote":1,"tweetType":1,"viewCount":2396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690059971,"gmtCreate":1639615627130,"gmtModify":1639615627236,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/690059971","repostId":"1172070133","repostType":4,"repost":{"id":"1172070133","kind":"news","pubTimestamp":1639621250,"share":"https://www.laohu8.com/m/news/1172070133?lang=zh_CN&edition=full","pubTime":"2021-12-16 10:20","market":"us","language":"en","title":"All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1172070133","media":"MarketWatch","summary":"The U.S. central bank charts a completely new course to attack inflation rather than continue to wai","content":"<p>The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out</p><p><blockquote>美联储制定了一条全新的路线来打击通胀，而不是继续等待通胀结束</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ba1b24817095f66e1cbf69b3dd7a4ad8\" tg-width=\"700\" tg-height=\"399\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy&nbsp;or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.</p><p><blockquote>美联储周三会议的重大消息并不是它将停止购买债券来刺激经济，也不是它现在暗示将在2022年三次上调基准贷款利率。过去一个月，美联储官员已经充分传达了这些短期政策决定。</blockquote></p><p> No, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.</p><p><blockquote>不，最令人惊讶的是，庞大的、厌恶变革的美联储对通胀的看法发生了180度的转变。</blockquote></p><p> The Fed’s statement&nbsp;Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.</p><p><blockquote>美联储周三的声明和附带的材料表明，鸽派——普遍认为通胀风险被夸大的政策制定者——已经完全投降。现在每个人都是鹰。美联储已经没有鸽派了。</blockquote></p><p> Fed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.</p><p><blockquote>美联储货币政策制定者一致认为，对抗通胀是他们的首要任务。他们可能在策略或时机上存在分歧，但在尽快战胜通胀的策略上却没有分歧。美联储处于战争状态，通胀是敌人。</blockquote></p><p> For 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.</p><p><blockquote>30年来，鸽派一直是对的：通货膨胀不是经济的最大威胁；失业是。鸽派打了一场最终成功的战斗，迫使美联储考虑失业给社会和经济留下的许多个人带来的非常真实的成本。</blockquote></p><p> But now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.</p><p><blockquote>但现在，冠状病毒大流行的影响甚至迫使鸽派接受通胀是比失业更大的威胁。对于一个不喜欢变化的机构来说，这是一个巨大的变化。</blockquote></p><p> How do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.</p><p><blockquote>我们怎么知道鸽子已经变成鹰了？看看点阵图，这是美联储每三个月发布一次的图表，显示了每个货币政策制定者对未来几年底联邦基金利率水平的匿名个人预测。</blockquote></p><p> Most analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.</p><p><blockquote>大多数分析师正确地关注来年的预测中值，但我想将您的注意力简要地转移到异常值（美联储最鹰派和鸽派成员）的中期预测上，以显示战场有多大自11月10日可怕的消费者价格指数数据以来，美联储内部发生了变化。那份报告改变了美联储的一切。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fc738ce106c9173e3b5b93bf435f87f7\" tg-width=\"700\" tg-height=\"644\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> In the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.</p><p><blockquote>在周三发布的最新预测中，最鹰派的成员将2023年底的中期预测从1.63%温和上调至2.13%，2024年底从2.63%上调至3.13%。五位最鹰派的成员现在认为，美联储将不得不将联邦基金利率推高至2.5%的假设长期均衡水平之上。</blockquote></p><p> But the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.</p><p><blockquote>但是鸽派彻底撕毁了他们之前的预测。五位最鸽派的成员此前预测，到2023年底，加息幅度将在零到两次之间，但现在他们预计加息四到五次。到2024年底，他们一直预测加息两到四次；现在他们预计是七个。</blockquote></p><p> Clearly, even the most dovish Fed officials now believe&nbsp;the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.</p><p><blockquote>显然，即使是最鸽派的美联储官员现在也认为，联邦基金利率必须大幅上升才能战胜通胀。以前，他们认为通货膨胀会自行下降。</blockquote></p><p> This means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.</p><p><blockquote>这意味着通货膨胀不再受益。它被证明是有罪的，即使是鸽派也会继续战争，直到取得胜利。对于美联储通胀鸽派来说，2021年11月10日有点像1941年12月7日：是时候开战了。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>All the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAll the doves at the Fed have become hawks<blockquote>美联储所有的鸽派都变成了鹰派</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-12-16 10:20</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out</p><p><blockquote>美联储制定了一条全新的路线来打击通胀，而不是继续等待通胀结束</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ba1b24817095f66e1cbf69b3dd7a4ad8\" tg-width=\"700\" tg-height=\"399\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy&nbsp;or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.</p><p><blockquote>美联储周三会议的重大消息并不是它将停止购买债券来刺激经济，也不是它现在暗示将在2022年三次上调基准贷款利率。过去一个月，美联储官员已经充分传达了这些短期政策决定。</blockquote></p><p> No, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.</p><p><blockquote>不，最令人惊讶的是，庞大的、厌恶变革的美联储对通胀的看法发生了180度的转变。</blockquote></p><p> The Fed’s statement&nbsp;Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.</p><p><blockquote>美联储周三的声明和附带的材料表明，鸽派——普遍认为通胀风险被夸大的政策制定者——已经完全投降。现在每个人都是鹰。美联储已经没有鸽派了。</blockquote></p><p> Fed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.</p><p><blockquote>美联储货币政策制定者一致认为，对抗通胀是他们的首要任务。他们可能在策略或时机上存在分歧，但在尽快战胜通胀的策略上却没有分歧。美联储处于战争状态，通胀是敌人。</blockquote></p><p> For 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.</p><p><blockquote>30年来，鸽派一直是对的：通货膨胀不是经济的最大威胁；失业是。鸽派打了一场最终成功的战斗，迫使美联储考虑失业给社会和经济留下的许多个人带来的非常真实的成本。</blockquote></p><p> But now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.</p><p><blockquote>但现在，冠状病毒大流行的影响甚至迫使鸽派接受通胀是比失业更大的威胁。对于一个不喜欢变化的机构来说，这是一个巨大的变化。</blockquote></p><p> How do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.</p><p><blockquote>我们怎么知道鸽子已经变成鹰了？看看点阵图，这是美联储每三个月发布一次的图表，显示了每个货币政策制定者对未来几年底联邦基金利率水平的匿名个人预测。</blockquote></p><p> Most analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.</p><p><blockquote>大多数分析师正确地关注来年的预测中值，但我想将您的注意力简要地转移到异常值（美联储最鹰派和鸽派成员）的中期预测上，以显示战场有多大自11月10日可怕的消费者价格指数数据以来，美联储内部发生了变化。那份报告改变了美联储的一切。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/fc738ce106c9173e3b5b93bf435f87f7\" tg-width=\"700\" tg-height=\"644\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> In the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.</p><p><blockquote>在周三发布的最新预测中，最鹰派的成员将2023年底的中期预测从1.63%温和上调至2.13%，2024年底从2.63%上调至3.13%。五位最鹰派的成员现在认为，美联储将不得不将联邦基金利率推高至2.5%的假设长期均衡水平之上。</blockquote></p><p> But the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.</p><p><blockquote>但是鸽派彻底撕毁了他们之前的预测。五位最鸽派的成员此前预测，到2023年底，加息幅度将在零到两次之间，但现在他们预计加息四到五次。到2024年底，他们一直预测加息两到四次；现在他们预计是七个。</blockquote></p><p> Clearly, even the most dovish Fed officials now believe&nbsp;the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.</p><p><blockquote>显然，即使是最鸽派的美联储官员现在也认为，联邦基金利率必须大幅上升才能战胜通胀。以前，他们认为通货膨胀会自行下降。</blockquote></p><p> This means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.</p><p><blockquote>这意味着通货膨胀不再受益。它被证明是有罪的，即使是鸽派也会继续战争，直到取得胜利。对于美联储通胀鸽派来说，2021年11月10日有点像1941年12月7日：是时候开战了。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/all-the-doves-at-the-fed-have-become-hawks-11639613760?mod=mw_latestnews\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/all-the-doves-at-the-fed-have-become-hawks-11639613760?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172070133","content_text":"The U.S. central bank charts a completely new course to attack inflation rather than continue to wait it out\n\nThe big news from the Federal Reserve’s meeting Wednesday wasn’t that it’ll stop buying bonds to stimulate the economy or that it’s now signaling three increases in its benchmark lending rate in 2022. Those short-term policy decisions had been well-telegraphed by Fed officials over the past month.\nNo, the big surprise is that the gargantuan, change-averse Fed has turned 180 degrees in its view of inflation.\nThe Fed’s statement Wednesday and the accompanying materials show that the doves — the policy makers who generally believe that the risk of inflation is overblown — have completely surrendered. Everyone’s a hawk now. There are no doves at the Fed anymore.\nFed monetary-policy makers unanimously agree that fighting inflation is their No. 1 job. They may disagree on the tactics or the timing, but not on the strategy of vanquishing inflation soon. The Fed is on a war footing, and inflation is the enemy.\nFor 30 years, the doves had been right: Inflation wasn’t the biggest threat to the economy; unemployment was. The doves fought an ultimately successful battle to force the Federal Reserve to consider the very real costs that unemployment forces upon society and the many individuals whom the economy was leaving behind.\nBut now effects of the coronavirus pandemic have forced even the doves to accept that inflation is a bigger threat than unemployment. That’s a huge change in an institution that doesn’t like change.\nHow do we know the doves have metamorphosed into hawks? Look at the dot plot, a chart the Fed releases every three months that shows the anonymous individual forecasts of each monetary-policy maker for the level of the federal funds rate at the ends of the next several years.\nMost analysts correctly focus on the median forecast for the coming year, but I’d like to redirect your attention briefly to the medium-term forecasts of the outliers, the most hawkish and dovish members of the Fed, to show how much the battlefield inside the Fed has changed since that horrendous consumer-price-index reading of Nov. 10. That report changed everything at the Fed.\n\nIn the latest forecasts released Wednesday, the most hawkish members raised their medium-term forecasts modestly from 1.63% to 2.13% at the end of 2023, and from 2.63% to 3.13% at the end of 2024. The five most hawkish members now think the Fed will have to push the fed funds rate above its assumed long-run equilibrium of 2.5%.\nBut the doves completely tore up their previous forecasts. The five most dovish members were forecasting between zero and two rate hikes by the end of 2023, but now they expect four or five. By the end of 2024, they had been forecasting between two and four rate hikes; now they expect seven.\nClearly, even the most dovish Fed officials now believe the fed funds rate must go up a lot to vanquish inflation. Before, they thought inflation would come down all by itself.\nThis means that inflation no longer gets the benefit of the doubt. It’s been proven guilty, and even the doves will prosecute the war until victory is won. For the inflation doves at the Fed, Nov. 10, 2021, was bit of like Dec. 7, 1941: Time to go to war.","news_type":1,"symbols_score_info":{".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3038,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843633000,"gmtCreate":1635822183811,"gmtModify":1635822183877,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/843633000","repostId":"2180209403","repostType":4,"isVote":1,"tweetType":1,"viewCount":497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":882126408,"gmtCreate":1631668390104,"gmtModify":1631888917475,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/882126408","repostId":"1148341685","repostType":4,"repost":{"id":"1148341685","kind":"news","pubTimestamp":1631660884,"share":"https://www.laohu8.com/m/news/1148341685?lang=zh_CN&edition=full","pubTime":"2021-09-15 07:08","market":"us","language":"en","title":"U.S. stocks close lower on worries over recovery, corporate tax hikes<blockquote>美国股市因对复苏和企业增税的担忧而收低</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148341685","media":"Reuters","summary":"NEW YORK (Reuters) - Wall Street lost ground on Tuesday as economic uncertainties and the increasing","content":"<p>NEW YORK (Reuters) - Wall Street lost ground on Tuesday as economic uncertainties and the increasing likelihood of a corporate tax rate hike dampened investor sentiment and prompted a broad sell-off despite signs of easing inflation.</p><p><blockquote>路透纽约-华尔街周二下跌，原因是经济不确定性和企业税率上调的可能性越来越大，抑制了投资者情绪，并引发了广泛的抛售，尽管通胀有缓解的迹象。</blockquote></p><p> Optimism faded throughout the session, reversing an initial rally following the Labor Department’s consumer price index report. All three major U.S. stock indexes ended in negative territory in a reminder that September is a historically rough month for stocks.</p><p><blockquote>整个交易日乐观情绪消退，扭转了劳工部消费者价格指数报告发布后最初的涨势。美国三大股指均收于负值，提醒人们9月份对于股市来说是历史上艰难的一个月。</blockquote></p><p> So far this month the S&amp;P 500 is down nearly 1.8% even as the benchmark index has gained over 18% since the beginning of the year.</p><p><blockquote>本月迄今为止，标普500已下跌近1.8%，尽管基准指数自年初以来已上涨超过18%。</blockquote></p><p> “There is a possibility that the market is simply ready to go through an overdue correction,” said Sam Stovall, chief investment strategist at CFRA Research in New York. “From a seasonality perspective, September tends to be the window dressing period for fund managers.”</p><p><blockquote>纽约CFRA Research首席投资策略师Sam Stovall表示：“市场有可能只是准备好经历一次迟来的调整。”“从季节性来看，9月往往是基金经理的粉饰期。”</blockquote></p><p> The advent of the highly contagious Delta COVID variant has driven an increase in bearish sentiment regarding the recovery from the global health crisis, and many now expect a substantial correction in stock markets by the end of the year.</p><p><blockquote>高度传染性的Delta COVID变种的出现导致人们对从全球健康危机中复苏的看跌情绪增加，许多人现在预计股市将在今年年底前大幅调整。</blockquote></p><p> “We’re still in a corrective mode that people have been calling for months,” said Paul Nolte, portfolio manager at Kingsview Asset Management in Chicago. “Economic data points have been missing estimates, and that has coincided with the rise in the Delta variant.”</p><p><blockquote>芝加哥Kingsview Asset Management投资组合经理保罗·诺尔特(Paul Nolte)表示：“我们仍处于人们几个月来一直呼吁的纠正模式。”“经济数据点一直低于预期，而这与德尔塔变异毒株的上升同时发生。”</blockquote></p><p> The CPI report delivered a lower-than-consensus August reading, a deceleration that supports Federal Reserve Chairman Jerome Powell’s assertion that spiking inflation is transitory and calms market fears that the central bank will begin tightening monetary policy sooner than expected.</p><p><blockquote>CPI报告公布的8月份读数低于市场普遍预期，这一减速支持了美联储主席杰罗姆·鲍威尔的说法，即通胀飙升是暂时的，并平息了市场对美联储将比预期更早开始收紧货币政策的担忧。</blockquote></p><p> U.S. Treasury yields dropped on the data, which pressured financial stocks, and investor favor pivoted back to growth at the expense of value. [US/]</p><p><blockquote>美国国债收益率因数据而下跌，这给金融股带来压力，投资者的青睐转向增长，而牺牲了价值。[美国/]</blockquote></p><p> The long expected corporate tax hikes, to 26.5% from 21% if Democrats prevail, are coming nearer to fruition with U.S. President Joe Biden’s $3.5 trillion budget package inching closer to passage.</p><p><blockquote>随着美国总统乔·拜登（Joe Biden）的3.5万亿美元预算计划逐渐接近通过，人们期待已久的公司税上调（如果民主党获胜，将从21%上调至26.5%）即将实现。</blockquote></p><p> The Dow Jones Industrial Average fell 292.06 points, or 0.84%, to 34,577.57; the S&amp;P 500 lost 25.68 points, or 0.57%, at 4,443.05; and the Nasdaq Composite dropped 67.82 points, or 0.45%, to 15,037.76.</p><p><blockquote>道琼工业指数跌292.06点，或0.84%，报34577.57点；标普500跌25.68点，跌幅0.57%，报4,443.05点；纳斯达克综合指数下跌67.82点，跌幅0.45%，至15037.76点。</blockquote></p><p> All 11 major sectors in the S&amp;P 500 ended the session red, with energy and financials suffering the largest percentage drops.</p><p><blockquote>标普500 11大板块全部收红，能源和金融板块跌幅最大。</blockquote></p><p> Apple Inc unveiled its iPhone 13 and added new features to its iPad and Apple Watch gadgets in its biggest product launch event of the year as the company faces increased scrutiny in the courts over its business practices. Its shares closed down 1.0% and were the heaviest drag on the S&amp;P 500 and the Nasdaq.</p><p><blockquote>苹果公司在今年最大的产品发布会上推出了iPhone 13，并为其iPad和苹果手表设备添加了新功能，因为该公司面临着法院对其商业行为的更严格审查。其股价收盘下跌1.0%，对标普500和纳斯达克拖累最大。</blockquote></p><p> Intuit Inc gained 1.9% following the TurboTax maker’s announcement that it would acquire digital marketing company Mailchimp for $12 billion.</p><p><blockquote>TurboTax制造商Intuit Inc宣布将以120亿美元收购数字营销公司Mailchimp后，该公司股价上涨1.9%。</blockquote></p><p> CureVac slid 8.0% after the German biotechnology company canceled manufacturing deals for its experimental COVID-19 vaccine.</p><p><blockquote>德国生物技术公司CureVac取消其实验性COVID-19疫苗的生产交易后，股价下跌8.0%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 2.25-to-1 ratio; on Nasdaq, a 2.40-to-1 ratio favored decliners.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为2.25比1；在纳斯达克，2.40比1的比率有利于下跌股。</blockquote></p><p> The S&amp;P 500 posted two new 52-week highs and two new lows; the Nasdaq Composite recorded 50 new highs and 107 new lows.</p><p><blockquote>标普500创下两个52周新高和两个新低；纳斯达克综合指数录得50个新高和107个新低。</blockquote></p><p> Volume on U.S. exchanges was 10.07 billion shares, compared with the 9.38 billion average over the last 20 trading days.</p><p><blockquote>美国交易所成交量为100.7亿股，而过去20个交易日的平均成交量为93.8亿股。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stocks close lower on worries over recovery, corporate tax hikes<blockquote>美国股市因对复苏和企业增税的担忧而收低</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stocks close lower on worries over recovery, corporate tax hikes<blockquote>美国股市因对复苏和企业增税的担忧而收低</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-09-15 07:08</span>\n</p>\n</h4>\n</header>\n<article>\n<p>NEW YORK (Reuters) - Wall Street lost ground on Tuesday as economic uncertainties and the increasing likelihood of a corporate tax rate hike dampened investor sentiment and prompted a broad sell-off despite signs of easing inflation.</p><p><blockquote>路透纽约-华尔街周二下跌，原因是经济不确定性和企业税率上调的可能性越来越大，抑制了投资者情绪，并引发了广泛的抛售，尽管通胀有缓解的迹象。</blockquote></p><p> Optimism faded throughout the session, reversing an initial rally following the Labor Department’s consumer price index report. All three major U.S. stock indexes ended in negative territory in a reminder that September is a historically rough month for stocks.</p><p><blockquote>整个交易日乐观情绪消退，扭转了劳工部消费者价格指数报告发布后最初的涨势。美国三大股指均收于负值，提醒人们9月份对于股市来说是历史上艰难的一个月。</blockquote></p><p> So far this month the S&amp;P 500 is down nearly 1.8% even as the benchmark index has gained over 18% since the beginning of the year.</p><p><blockquote>本月迄今为止，标普500已下跌近1.8%，尽管基准指数自年初以来已上涨超过18%。</blockquote></p><p> “There is a possibility that the market is simply ready to go through an overdue correction,” said Sam Stovall, chief investment strategist at CFRA Research in New York. “From a seasonality perspective, September tends to be the window dressing period for fund managers.”</p><p><blockquote>纽约CFRA Research首席投资策略师Sam Stovall表示：“市场有可能只是准备好经历一次迟来的调整。”“从季节性来看，9月往往是基金经理的粉饰期。”</blockquote></p><p> The advent of the highly contagious Delta COVID variant has driven an increase in bearish sentiment regarding the recovery from the global health crisis, and many now expect a substantial correction in stock markets by the end of the year.</p><p><blockquote>高度传染性的Delta COVID变种的出现导致人们对从全球健康危机中复苏的看跌情绪增加，许多人现在预计股市将在今年年底前大幅调整。</blockquote></p><p> “We’re still in a corrective mode that people have been calling for months,” said Paul Nolte, portfolio manager at Kingsview Asset Management in Chicago. “Economic data points have been missing estimates, and that has coincided with the rise in the Delta variant.”</p><p><blockquote>芝加哥Kingsview Asset Management投资组合经理保罗·诺尔特(Paul Nolte)表示：“我们仍处于人们几个月来一直呼吁的纠正模式。”“经济数据点一直低于预期，而这与德尔塔变异毒株的上升同时发生。”</blockquote></p><p> The CPI report delivered a lower-than-consensus August reading, a deceleration that supports Federal Reserve Chairman Jerome Powell’s assertion that spiking inflation is transitory and calms market fears that the central bank will begin tightening monetary policy sooner than expected.</p><p><blockquote>CPI报告公布的8月份读数低于市场普遍预期，这一减速支持了美联储主席杰罗姆·鲍威尔的说法，即通胀飙升是暂时的，并平息了市场对美联储将比预期更早开始收紧货币政策的担忧。</blockquote></p><p> U.S. Treasury yields dropped on the data, which pressured financial stocks, and investor favor pivoted back to growth at the expense of value. [US/]</p><p><blockquote>美国国债收益率因数据而下跌，这给金融股带来压力，投资者的青睐转向增长，而牺牲了价值。[美国/]</blockquote></p><p> The long expected corporate tax hikes, to 26.5% from 21% if Democrats prevail, are coming nearer to fruition with U.S. President Joe Biden’s $3.5 trillion budget package inching closer to passage.</p><p><blockquote>随着美国总统乔·拜登（Joe Biden）的3.5万亿美元预算计划逐渐接近通过，人们期待已久的公司税上调（如果民主党获胜，将从21%上调至26.5%）即将实现。</blockquote></p><p> The Dow Jones Industrial Average fell 292.06 points, or 0.84%, to 34,577.57; the S&amp;P 500 lost 25.68 points, or 0.57%, at 4,443.05; and the Nasdaq Composite dropped 67.82 points, or 0.45%, to 15,037.76.</p><p><blockquote>道琼工业指数跌292.06点，或0.84%，报34577.57点；标普500跌25.68点，跌幅0.57%，报4,443.05点；纳斯达克综合指数下跌67.82点，跌幅0.45%，至15037.76点。</blockquote></p><p> All 11 major sectors in the S&amp;P 500 ended the session red, with energy and financials suffering the largest percentage drops.</p><p><blockquote>标普500 11大板块全部收红，能源和金融板块跌幅最大。</blockquote></p><p> Apple Inc unveiled its iPhone 13 and added new features to its iPad and Apple Watch gadgets in its biggest product launch event of the year as the company faces increased scrutiny in the courts over its business practices. Its shares closed down 1.0% and were the heaviest drag on the S&amp;P 500 and the Nasdaq.</p><p><blockquote>苹果公司在今年最大的产品发布会上推出了iPhone 13，并为其iPad和苹果手表设备添加了新功能，因为该公司面临着法院对其商业行为的更严格审查。其股价收盘下跌1.0%，对标普500和纳斯达克拖累最大。</blockquote></p><p> Intuit Inc gained 1.9% following the TurboTax maker’s announcement that it would acquire digital marketing company Mailchimp for $12 billion.</p><p><blockquote>TurboTax制造商Intuit Inc宣布将以120亿美元收购数字营销公司Mailchimp后，该公司股价上涨1.9%。</blockquote></p><p> CureVac slid 8.0% after the German biotechnology company canceled manufacturing deals for its experimental COVID-19 vaccine.</p><p><blockquote>德国生物技术公司CureVac取消其实验性COVID-19疫苗的生产交易后，股价下跌8.0%。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 2.25-to-1 ratio; on Nasdaq, a 2.40-to-1 ratio favored decliners.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为2.25比1；在纳斯达克，2.40比1的比率有利于下跌股。</blockquote></p><p> The S&amp;P 500 posted two new 52-week highs and two new lows; the Nasdaq Composite recorded 50 new highs and 107 new lows.</p><p><blockquote>标普500创下两个52周新高和两个新低；纳斯达克综合指数录得50个新高和107个新低。</blockquote></p><p> Volume on U.S. exchanges was 10.07 billion shares, compared with the 9.38 billion average over the last 20 trading days.</p><p><blockquote>美国交易所成交量为100.7亿股，而过去20个交易日的平均成交量为93.8亿股。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/usa-stocks/u-s-stocks-close-lower-on-worries-over-recovery-corporate-tax-hikes-idUSKBN2GA0W9\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.reuters.com/article/usa-stocks/u-s-stocks-close-lower-on-worries-over-recovery-corporate-tax-hikes-idUSKBN2GA0W9","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148341685","content_text":"NEW YORK (Reuters) - Wall Street lost ground on Tuesday as economic uncertainties and the increasing likelihood of a corporate tax rate hike dampened investor sentiment and prompted a broad sell-off despite signs of easing inflation.\nOptimism faded throughout the session, reversing an initial rally following the Labor Department’s consumer price index report. All three major U.S. stock indexes ended in negative territory in a reminder that September is a historically rough month for stocks.\nSo far this month the S&P 500 is down nearly 1.8% even as the benchmark index has gained over 18% since the beginning of the year.\n“There is a possibility that the market is simply ready to go through an overdue correction,” said Sam Stovall, chief investment strategist at CFRA Research in New York. “From a seasonality perspective, September tends to be the window dressing period for fund managers.”\nThe advent of the highly contagious Delta COVID variant has driven an increase in bearish sentiment regarding the recovery from the global health crisis, and many now expect a substantial correction in stock markets by the end of the year.\n“We’re still in a corrective mode that people have been calling for months,” said Paul Nolte, portfolio manager at Kingsview Asset Management in Chicago. “Economic data points have been missing estimates, and that has coincided with the rise in the Delta variant.”\nThe CPI report delivered a lower-than-consensus August reading, a deceleration that supports Federal Reserve Chairman Jerome Powell’s assertion that spiking inflation is transitory and calms market fears that the central bank will begin tightening monetary policy sooner than expected.\nU.S. Treasury yields dropped on the data, which pressured financial stocks, and investor favor pivoted back to growth at the expense of value. [US/]\nThe long expected corporate tax hikes, to 26.5% from 21% if Democrats prevail, are coming nearer to fruition with U.S. President Joe Biden’s $3.5 trillion budget package inching closer to passage.\nThe Dow Jones Industrial Average fell 292.06 points, or 0.84%, to 34,577.57; the S&P 500 lost 25.68 points, or 0.57%, at 4,443.05; and the Nasdaq Composite dropped 67.82 points, or 0.45%, to 15,037.76.\nAll 11 major sectors in the S&P 500 ended the session red, with energy and financials suffering the largest percentage drops.\nApple Inc unveiled its iPhone 13 and added new features to its iPad and Apple Watch gadgets in its biggest product launch event of the year as the company faces increased scrutiny in the courts over its business practices. Its shares closed down 1.0% and were the heaviest drag on the S&P 500 and the Nasdaq.\nIntuit Inc gained 1.9% following the TurboTax maker’s announcement that it would acquire digital marketing company Mailchimp for $12 billion.\nCureVac slid 8.0% after the German biotechnology company canceled manufacturing deals for its experimental COVID-19 vaccine.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.25-to-1 ratio; on Nasdaq, a 2.40-to-1 ratio favored decliners.\nThe S&P 500 posted two new 52-week highs and two new lows; the Nasdaq Composite recorded 50 new highs and 107 new lows.\nVolume on U.S. exchanges was 10.07 billion shares, compared with the 9.38 billion average over the last 20 trading days.","news_type":1,"symbols_score_info":{".IXIC":0.9,".SPX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837334996,"gmtCreate":1629856604115,"gmtModify":1631891867720,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/837334996","repostId":"2162087564","repostType":4,"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839919304,"gmtCreate":1629115220808,"gmtModify":1631893764041,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/839919304","repostId":"2159248377","repostType":4,"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":824932844,"gmtCreate":1634268041573,"gmtModify":1634274404573,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/824932844","repostId":"1129314610","repostType":4,"repost":{"id":"1129314610","kind":"news","pubTimestamp":1634253682,"share":"https://www.laohu8.com/m/news/1129314610?lang=zh_CN&edition=full","pubTime":"2021-10-15 07:21","market":"us","language":"en","title":"S&P 500 surges, biggest daily percentage rise since March on earnings, data<blockquote>标普500股价飙升，盈利和数据创3月份以来最大单日百分比涨幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1129314610","media":"Reuters","summary":"NEW YORK (Reuters) - The S&P 500 jumped on Thursday, its biggest daily percentage advance since earl","content":"<p>NEW YORK (Reuters) - The S&amp;P 500 jumped on Thursday, its biggest daily percentage advance since early March, as companies including <a href=\"https://laohu8.com/S/MS\">Morgan Stanley</a> and <a href=\"https://laohu8.com/S/UNH\">UnitedHealth</a> climbed following strong results, while data on the labor market and inflation soothed fears over the outlook for higher rates.</p><p><blockquote>纽约（路透社）-标普500周四跳涨，创3月初以来最大单日百分比涨幅，包括<a href=\"https://laohu8.com/S/MS\">摩根士丹利</a>和<a href=\"https://laohu8.com/S/UNH\">联合健康</a>在强劲的业绩后攀升，而劳动力市场和通胀数据缓解了对加息前景的担忧。</blockquote></p><p> The technology sector jumped 2.3%, giving the S&amp;P 500 its biggest boost, with shares of <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> Corp and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc rising.</p><p><blockquote>科技板块上涨2.3%，给标普500带来最大提振，股价为<a href=\"https://laohu8.com/S/MSFT\">微软</a>公司和<a href=\"https://laohu8.com/S/AAPL\">苹果</a>公司崛起。</blockquote></p><p> Shares of <a href=\"https://laohu8.com/S/C\">Citigroup</a>, $Bank of America Corp(BAC-N)$ and <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> also gained after they topped quarterly earnings estimates. The rebounding economy allowed them to release more cash they had set aside for pandemic losses, while sizzling deals, equity financing and trading added to profits. The S&amp;P bank index jumped 1.5%.</p><p><blockquote>本公司之股份<a href=\"https://laohu8.com/S/C\">花旗集团</a>,$美国银行(BAC-N)$和<a href=\"https://laohu8.com/S/MSTLW\">摩根士丹利</a>在超出季度盈利预期后也有所上涨。经济的反弹使他们能够释放更多为疫情损失预留的现金，而火热的交易、股权融资和交易增加了利润。标准普尔银行指数上涨1.5%。</blockquote></p><p> Also, UnitedHealth Group Inc climbed 4.2% after the health insurer reported results and raised its full-year adjusted profit forecast on strength from its Optum unit that manages drug benefits.</p><p><blockquote>此外，联合健康集团(UnitedHealth Group Inc)股价上涨4.2%，此前该健康保险公司公布了业绩，并因其管理药品福利的Optum部门的实力而上调了全年调整后利润预测。</blockquote></p><p> Adding to optimism, data showed the number of Americans filing new claims for unemployment benefits last week fell close to a 19-month low, and a separate report showed producer prices eased in September.</p><p><blockquote>数据显示，上周美国新申请失业救济人数降至接近19个月低点，另一份报告显示，9月份生产者价格有所放缓，这增加了乐观情绪。</blockquote></p><p> Data from recent inflation reports suggested COVID-driven price increases may have peaked. Still, Federal Reserve policymakers remain divided over inflation and what to do about it.</p><p><blockquote>最近通胀报告的数据表明，新冠疫情推动的价格上涨可能已经见顶。尽管如此，美联储政策制定者在通胀以及如何应对通胀问题上仍存在分歧。</blockquote></p><p> “Some of the things that worried the market in September, and even last week, as far as the inflation aspect and higher interest rates and the Delta variant, maybe have lessened,” said Alan Lancz, president, Alan B. Lancz &amp; Associates Inc., an investment advisory firm, based in Toledo, Ohio.</p><p><blockquote>Alan B.Lancz&amp;Associates Inc.总裁Alan Lancz表示：“9月份甚至上周令市场担忧的一些事情，就通胀、利率上升和德尔塔变异毒株而言，可能已经有所缓解。”</blockquote></p><p> “Not that it’s all over, but on a temporary scale at least, you can make a case for it trending in the right direction.”</p><p><blockquote>“并不是说一切都结束了，但至少在暂时的范围内，你可以证明它正朝着正确的方向发展。”</blockquote></p><p> The Dow Jones Industrial Average rose 534.75 points, or 1.56%, to 34,912.56, the S&amp;P 500 gained 74.46 points, or 1.71%, to 4,438.26 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite added 251.8 points, or 1.73%, to 14,823.43.</p><p><blockquote>道琼斯工业平均指数上涨534.75点，涨幅1.56%，至34,912.56点；标普500上涨74.46点，涨幅1.71%，至4,438.26点；<a href=\"https://laohu8.com/S/NDAQ\">纳斯达克</a>综合指数上涨251.8点，或1.73%，至14,823.43点。</blockquote></p><p> While the S&amp;P 500 registered its biggest daily percentage gain since March 5, the Nasdaq notched its biggest since May 20 and the Dow its biggest since July 20.</p><p><blockquote>虽然标普500创下3月5日以来最大单日百分比涨幅，但纳斯达克创下5月20日以来最大涨幅，道琼斯指数创下7月20日以来最大涨幅。</blockquote></p><p> Gains were broad-based, with all but <a href=\"https://laohu8.com/S/AONE.U\">one</a> S&amp;P 500 sector rising more than 1%.</p><p><blockquote>收益基础广泛，除了<a href=\"https://laohu8.com/S/AONE.U\">一</a>标普500板块涨超1%。</blockquote></p><p> Shares of Moderna Inc ended up 3.2% after a panel of expert advisers to the U.S. Food and Drug Administration voted to recommend booster shots of its COVID-19 vaccine for Americans aged 65 and older and those at high risk of severe illness.</p><p><blockquote>美国专家顾问小组表示，Moderna Inc.的股价最终上涨3.2%。美国食品药品监督管理局投票建议为65岁及以上的美国人和患有严重疾病的高风险人群注射新冠肺炎疫苗。</blockquote></p><p> <a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc jumped 7.4% after the drugstore chain reported fourth-quarter revenue and adjusted profit above estimates and forecast growth of 11% to 13% in the long term.</p><p><blockquote><a href=\"https://laohu8.com/S/WBA\">沃尔格林靴子联盟</a>Inc股价上涨7.4%，此前这家连锁药店公布第四季度营收和调整后利润高于预期，并预测长期增长率为11%至13%。</blockquote></p><p> U.S. companies are expected to report strong profit growth for the third quarter, but investors have been keen to hear what they say about rising costs, labor shortages and supply problems.</p><p><blockquote>预计美国企业将公布第三季度强劲的利润增长，但投资者一直渴望听到他们对成本上升、劳动力短缺和供应问题的看法。</blockquote></p><p> Advancing issues outnumbered declining ones on the NYSE by a 3.58-to-1 ratio; on Nasdaq, a 1.97-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所上涨股与下跌股的比例为3.58比1；在纳斯达克，1.97比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 32 new 52-week highs and no new lows; the Nasdaq Composite recorded 82 new highs and 46 new lows.</p><p><blockquote>标普500创下32个52周新高，无新低；纳斯达克综合指数录得82个新高和46个新低。</blockquote></p><p> Volume on U.S. exchanges was 9.26 billion shares, compared with the 10.8 billion average for the full session over the last 20 trading days.</p><p><blockquote>美国交易所的成交量为92.6亿股，而过去20个交易日的平均成交量为108亿股。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 surges, biggest daily percentage rise since March on earnings, data<blockquote>标普500股价飙升，盈利和数据创3月份以来最大单日百分比涨幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 surges, biggest daily percentage rise since March on earnings, data<blockquote>标普500股价飙升，盈利和数据创3月份以来最大单日百分比涨幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-10-15 07:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>NEW YORK (Reuters) - The S&amp;P 500 jumped on Thursday, its biggest daily percentage advance since early March, as companies including <a href=\"https://laohu8.com/S/MS\">Morgan Stanley</a> and <a href=\"https://laohu8.com/S/UNH\">UnitedHealth</a> climbed following strong results, while data on the labor market and inflation soothed fears over the outlook for higher rates.</p><p><blockquote>纽约（路透社）-标普500周四跳涨，创3月初以来最大单日百分比涨幅，包括<a href=\"https://laohu8.com/S/MS\">摩根士丹利</a>和<a href=\"https://laohu8.com/S/UNH\">联合健康</a>在强劲的业绩后攀升，而劳动力市场和通胀数据缓解了对加息前景的担忧。</blockquote></p><p> The technology sector jumped 2.3%, giving the S&amp;P 500 its biggest boost, with shares of <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> Corp and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc rising.</p><p><blockquote>科技板块上涨2.3%，给标普500带来最大提振，股价为<a href=\"https://laohu8.com/S/MSFT\">微软</a>公司和<a href=\"https://laohu8.com/S/AAPL\">苹果</a>公司崛起。</blockquote></p><p> Shares of <a href=\"https://laohu8.com/S/C\">Citigroup</a>, $Bank of America Corp(BAC-N)$ and <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> also gained after they topped quarterly earnings estimates. The rebounding economy allowed them to release more cash they had set aside for pandemic losses, while sizzling deals, equity financing and trading added to profits. The S&amp;P bank index jumped 1.5%.</p><p><blockquote>本公司之股份<a href=\"https://laohu8.com/S/C\">花旗集团</a>,$美国银行(BAC-N)$和<a href=\"https://laohu8.com/S/MSTLW\">摩根士丹利</a>在超出季度盈利预期后也有所上涨。经济的反弹使他们能够释放更多为疫情损失预留的现金，而火热的交易、股权融资和交易增加了利润。标准普尔银行指数上涨1.5%。</blockquote></p><p> Also, UnitedHealth Group Inc climbed 4.2% after the health insurer reported results and raised its full-year adjusted profit forecast on strength from its Optum unit that manages drug benefits.</p><p><blockquote>此外，联合健康集团(UnitedHealth Group Inc)股价上涨4.2%，此前该健康保险公司公布了业绩，并因其管理药品福利的Optum部门的实力而上调了全年调整后利润预测。</blockquote></p><p> Adding to optimism, data showed the number of Americans filing new claims for unemployment benefits last week fell close to a 19-month low, and a separate report showed producer prices eased in September.</p><p><blockquote>数据显示，上周美国新申请失业救济人数降至接近19个月低点，另一份报告显示，9月份生产者价格有所放缓，这增加了乐观情绪。</blockquote></p><p> Data from recent inflation reports suggested COVID-driven price increases may have peaked. Still, Federal Reserve policymakers remain divided over inflation and what to do about it.</p><p><blockquote>最近通胀报告的数据表明，新冠疫情推动的价格上涨可能已经见顶。尽管如此，美联储政策制定者在通胀以及如何应对通胀问题上仍存在分歧。</blockquote></p><p> “Some of the things that worried the market in September, and even last week, as far as the inflation aspect and higher interest rates and the Delta variant, maybe have lessened,” said Alan Lancz, president, Alan B. Lancz &amp; Associates Inc., an investment advisory firm, based in Toledo, Ohio.</p><p><blockquote>Alan B.Lancz&amp;Associates Inc.总裁Alan Lancz表示：“9月份甚至上周令市场担忧的一些事情，就通胀、利率上升和德尔塔变异毒株而言，可能已经有所缓解。”</blockquote></p><p> “Not that it’s all over, but on a temporary scale at least, you can make a case for it trending in the right direction.”</p><p><blockquote>“并不是说一切都结束了，但至少在暂时的范围内，你可以证明它正朝着正确的方向发展。”</blockquote></p><p> The Dow Jones Industrial Average rose 534.75 points, or 1.56%, to 34,912.56, the S&amp;P 500 gained 74.46 points, or 1.71%, to 4,438.26 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite added 251.8 points, or 1.73%, to 14,823.43.</p><p><blockquote>道琼斯工业平均指数上涨534.75点，涨幅1.56%，至34,912.56点；标普500上涨74.46点，涨幅1.71%，至4,438.26点；<a href=\"https://laohu8.com/S/NDAQ\">纳斯达克</a>综合指数上涨251.8点，或1.73%，至14,823.43点。</blockquote></p><p> While the S&amp;P 500 registered its biggest daily percentage gain since March 5, the Nasdaq notched its biggest since May 20 and the Dow its biggest since July 20.</p><p><blockquote>虽然标普500创下3月5日以来最大单日百分比涨幅，但纳斯达克创下5月20日以来最大涨幅，道琼斯指数创下7月20日以来最大涨幅。</blockquote></p><p> Gains were broad-based, with all but <a href=\"https://laohu8.com/S/AONE.U\">one</a> S&amp;P 500 sector rising more than 1%.</p><p><blockquote>收益基础广泛，除了<a href=\"https://laohu8.com/S/AONE.U\">一</a>标普500板块涨超1%。</blockquote></p><p> Shares of Moderna Inc ended up 3.2% after a panel of expert advisers to the U.S. Food and Drug Administration voted to recommend booster shots of its COVID-19 vaccine for Americans aged 65 and older and those at high risk of severe illness.</p><p><blockquote>美国专家顾问小组表示，Moderna Inc.的股价最终上涨3.2%。美国食品药品监督管理局投票建议为65岁及以上的美国人和患有严重疾病的高风险人群注射新冠肺炎疫苗。</blockquote></p><p> <a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> Inc jumped 7.4% after the drugstore chain reported fourth-quarter revenue and adjusted profit above estimates and forecast growth of 11% to 13% in the long term.</p><p><blockquote><a href=\"https://laohu8.com/S/WBA\">沃尔格林靴子联盟</a>Inc股价上涨7.4%，此前这家连锁药店公布第四季度营收和调整后利润高于预期，并预测长期增长率为11%至13%。</blockquote></p><p> U.S. companies are expected to report strong profit growth for the third quarter, but investors have been keen to hear what they say about rising costs, labor shortages and supply problems.</p><p><blockquote>预计美国企业将公布第三季度强劲的利润增长，但投资者一直渴望听到他们对成本上升、劳动力短缺和供应问题的看法。</blockquote></p><p> Advancing issues outnumbered declining ones on the NYSE by a 3.58-to-1 ratio; on Nasdaq, a 1.97-to-1 ratio favored advancers.</p><p><blockquote>纽约证券交易所上涨股与下跌股的比例为3.58比1；在纳斯达克，1.97比1的比率有利于上涨者。</blockquote></p><p> The S&amp;P 500 posted 32 new 52-week highs and no new lows; the Nasdaq Composite recorded 82 new highs and 46 new lows.</p><p><blockquote>标普500创下32个52周新高，无新低；纳斯达克综合指数录得82个新高和46个新低。</blockquote></p><p> Volume on U.S. exchanges was 9.26 billion shares, compared with the 10.8 billion average for the full session over the last 20 trading days.</p><p><blockquote>美国交易所的成交量为92.6亿股，而过去20个交易日的平均成交量为108亿股。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-surges-biggest-daily-percentage-rise-since-march-on-earnings-data-idUSL1N2RA2WC\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","OEX":"标普100",".DJI":"道琼斯","SSO":"2倍做多标普500ETF-ProShares","SPXU":"三倍做空标普500ETF-ProShares","IVV":"标普500ETF-iShares","UPRO":"三倍做多标普500ETF-ProShares",".IXIC":"NASDAQ Composite","SH":"做空标普500-Proshares",".SPX":"S&P 500 Index","SDS":"两倍做空标普500 ETF-ProShares","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-surges-biggest-daily-percentage-rise-since-march-on-earnings-data-idUSL1N2RA2WC","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129314610","content_text":"NEW YORK (Reuters) - The S&P 500 jumped on Thursday, its biggest daily percentage advance since early March, as companies including Morgan Stanley and UnitedHealth climbed following strong results, while data on the labor market and inflation soothed fears over the outlook for higher rates.\nThe technology sector jumped 2.3%, giving the S&P 500 its biggest boost, with shares of Microsoft Corp and Apple Inc rising.\nShares of Citigroup, $Bank of America Corp(BAC-N)$ and Morgan Stanley also gained after they topped quarterly earnings estimates. The rebounding economy allowed them to release more cash they had set aside for pandemic losses, while sizzling deals, equity financing and trading added to profits. The S&P bank index jumped 1.5%.\nAlso, UnitedHealth Group Inc climbed 4.2% after the health insurer reported results and raised its full-year adjusted profit forecast on strength from its Optum unit that manages drug benefits.\nAdding to optimism, data showed the number of Americans filing new claims for unemployment benefits last week fell close to a 19-month low, and a separate report showed producer prices eased in September.\nData from recent inflation reports suggested COVID-driven price increases may have peaked. Still, Federal Reserve policymakers remain divided over inflation and what to do about it.\n“Some of the things that worried the market in September, and even last week, as far as the inflation aspect and higher interest rates and the Delta variant, maybe have lessened,” said Alan Lancz, president, Alan B. Lancz & Associates Inc., an investment advisory firm, based in Toledo, Ohio.\n“Not that it’s all over, but on a temporary scale at least, you can make a case for it trending in the right direction.”\nThe Dow Jones Industrial Average rose 534.75 points, or 1.56%, to 34,912.56, the S&P 500 gained 74.46 points, or 1.71%, to 4,438.26 and the Nasdaq Composite added 251.8 points, or 1.73%, to 14,823.43.\nWhile the S&P 500 registered its biggest daily percentage gain since March 5, the Nasdaq notched its biggest since May 20 and the Dow its biggest since July 20.\nGains were broad-based, with all but one S&P 500 sector rising more than 1%.\nShares of Moderna Inc ended up 3.2% after a panel of expert advisers to the U.S. Food and Drug Administration voted to recommend booster shots of its COVID-19 vaccine for Americans aged 65 and older and those at high risk of severe illness.\nWalgreens Boots Alliance Inc jumped 7.4% after the drugstore chain reported fourth-quarter revenue and adjusted profit above estimates and forecast growth of 11% to 13% in the long term.\nU.S. companies are expected to report strong profit growth for the third quarter, but investors have been keen to hear what they say about rising costs, labor shortages and supply problems.\nAdvancing issues outnumbered declining ones on the NYSE by a 3.58-to-1 ratio; on Nasdaq, a 1.97-to-1 ratio favored advancers.\nThe S&P 500 posted 32 new 52-week highs and no new lows; the Nasdaq Composite recorded 82 new highs and 46 new lows.\nVolume on U.S. exchanges was 9.26 billion shares, compared with the 10.8 billion average for the full session over the last 20 trading days.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,"ESmain":0.9,"UPRO":0.9,"OEX":0.9,".SPX":0.9,"OEF":0.9,"SSO":0.9,"SH":0.9,".IXIC":0.9,"SPXU":0.9,"SPY":0.9,".DJI":0.9,"IVV":0.9,"SDS":0.9}},"isVote":1,"tweetType":1,"viewCount":542,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821403952,"gmtCreate":1633767019615,"gmtModify":1633767019615,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/821403952","repostId":"2174920514","repostType":4,"isVote":1,"tweetType":1,"viewCount":810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865713756,"gmtCreate":1633017656068,"gmtModify":1633017656227,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/865713756","repostId":"2171895899","repostType":4,"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":814092018,"gmtCreate":1630725026734,"gmtModify":1631888917595,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/814092018","repostId":"1186003479","repostType":4,"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806901430,"gmtCreate":1627621300420,"gmtModify":1633757675608,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/806901430","repostId":"2155184148","repostType":4,"isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":699270807,"gmtCreate":1639824405751,"gmtModify":1639824405859,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699270807","repostId":"1189235922","repostType":4,"repost":{"id":"1189235922","kind":"news","pubTimestamp":1639809269,"share":"https://www.laohu8.com/m/news/1189235922?lang=zh_CN&edition=full","pubTime":"2021-12-18 14:34","market":"us","language":"en","title":"DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189235922","media":"Seeking Alpha","summary":"DaVita  Board of Directors increased the authorization under the existing share repurchase program b","content":"<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p><p><blockquote><a href=\"https://laohu8.com/S/DVA\">达维塔</a>董事会将现有股票回购计划下的授权增加了20亿美元的额外回购授权。</blockquote></p><p> The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p><p><blockquote>根据新授权授权回购的股份金额不包括2020年12月10日授权的公司现有股份回购计划下剩余的金额。</blockquote></p><p> Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p><p><blockquote>SA撰稿人对该股发表了一些看跌评论和评级，他写道：“该公司似乎被高估，该公司未来面临几项挑战。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita authorizes additional $2B share repurchase<blockquote>DaVita授权额外回购20亿美元股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-18 14:34</span>\n</p>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/DVA\">DaVita </a> Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.</p><p><blockquote><a href=\"https://laohu8.com/S/DVA\">达维塔</a>董事会将现有股票回购计划下的授权增加了20亿美元的额外回购授权。</blockquote></p><p> The amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .</p><p><blockquote>根据新授权授权回购的股份金额不包括2020年12月10日授权的公司现有股份回购计划下剩余的金额。</blockquote></p><p> Some bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'</p><p><blockquote>SA撰稿人对该股发表了一些看跌评论和评级，他写道：“该公司似乎被高估，该公司未来面临几项挑战。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DVA":"达维塔保健"},"source_url":"https://seekingalpha.com/news/3781473-davita-authorizes-additional-2b-share-repurchase","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189235922","content_text":"DaVita  Board of Directors increased the authorization under the existing share repurchase program by $2B in additional repurchasing authority.\nThe amount of shares authorized to be repurchased under the new authorization does not include the amount remaining under the company’s existing share repurchase program authorized on December 10, 2020 .\nSome bearish commentary and rating on the stock by SA contributor who writes: 'The company appears to be overvalued, and there are several challenges facing the company in the future.'","news_type":1,"symbols_score_info":{"DVA":0.9}},"isVote":1,"tweetType":1,"viewCount":2099,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872026671,"gmtCreate":1637378019821,"gmtModify":1637378019993,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/872026671","repostId":"1111549440","repostType":4,"repost":{"id":"1111549440","kind":"news","pubTimestamp":1637372002,"share":"https://www.laohu8.com/m/news/1111549440?lang=zh_CN&edition=full","pubTime":"2021-11-20 09:33","market":"us","language":"en","title":"Bristol Myers Stock Keeps Skidding on FDA Heart Drug Review<blockquote>百时美施贵宝股价因FDA心脏药物审查而持续下滑</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1111549440","media":"The Street","summary":"$Bristol Myers Squibb (BMY)$ shares fell Friday after the pharmaceutical titan said the FDA has exte","content":"<p>$Bristol Myers Squibb&nbsp;(<b>BMY</b>)$&nbsp;shares fell Friday after the pharmaceutical titan said the FDA has extended its review of heart drug mavacamten for three months, until April 28.</p><p><blockquote>$百时美施贵宝(<b>BMY</b>)$股价周五下跌，此前这家制药巨头表示FDA已将心脏药物mavacamten的审查延长三个月，直至4月28日。</blockquote></p><p> The drug treats symptomatic obstructive hypertrophic cardiomyopathy (oHCM).</p><p><blockquote>该药物治疗症状性梗阻性肥厚型心肌病（oHCM）。</blockquote></p><p> The Food and Drug Administration notified Bristol Thursday of the extension “to allow sufficient time to review information pertaining to updates to the proposed Risk Evaluation Mitigation Strategy (REMS),” the company said.</p><p><blockquote>该公司表示，美国食品和药物管理局周四通知布里斯托尔延期，“以便有足够的时间审查与拟议风险评估缓解策略（REMS）更新相关的信息”。</blockquote></p><p> “A REMS program was included in the initial application for mavacamten. No additional data or studies have been requested.”</p><p><blockquote>“mavacamten的初始申请中包含了REMS计划。没有要求额外的数据或研究。”</blockquote></p><p> Bristol Myers recently traded at $58.07, down 1.6%. It has slid 14% over the past three months.</p><p><blockquote>百时美施贵宝近期交易价格为58.07美元，下跌1.6%。过去三个月下跌了14%。</blockquote></p><p> “We are confident in the profile of mavacamten,” said Samit Hirawat, chief medical officer, global drug development at Bristol Myers.</p><p><blockquote>百时美施贵宝全球药物开发首席医疗官Samit Hirawat表示：“我们对mavacamten的前景充满信心。”</blockquote></p><p> “This first-in-class cardiac myosin inhibitor demonstrated clinically meaningful improvements in symptoms, functional status, and quality of life in symptomatic oHCM patients in the pivotal EXPLORER-HCM trial.”</p><p><blockquote>“在关键的EXPLORER-HCM试验中，这种一流的心肌肌球蛋白抑制剂在有症状的oHCM患者的症状、功能状态和生活质量方面表现出了具有临床意义的改善。”</blockquote></p><p> Mavacamten represented the top potential drug of MyoKardia, which Bristol Myers acquired last year for $13.1 billion, MarketWatch reports.</p><p><blockquote>据MarketWatch报道，Mavacamten是MyoKardia最具潜力的药物，百时美施贵宝去年以131亿美元收购了该药物。</blockquote></p><p> Morningstar analyst Damien Conover puts fair value for Bristol Myers at $68.</p><p><blockquote>晨星分析师Damien Conover认为百时美施贵宝的公允价值为68美元。</blockquote></p><p> “Bristol Myers hosted an investor day highlighting a strong pipeline that holds the potential to offset the firm’s major patent losses over the next decade, a key element supporting our wide moat rating,” he wrote in a commentary Tuesday.</p><p><blockquote>他在周二的评论中写道：“百时美施贵宝举办了投资者日活动，强调了强大的产品线，有可能抵消该公司未来十年的重大专利损失，这是支持我们宽护城河评级的关键因素。”</blockquote></p><p> “With most of the updates focused on still risky early-stage pipeline assets, the updates didn’t move our fair value estimate. However, we continue to view the stock as undervalued with the market not fully appreciating the firm’s late-stage pipeline.”</p><p><blockquote>“由于大多数更新都集中在仍然有风险的早期管道资产上，因此这些更新并没有改变我们的公允价值估计。然而，我们仍然认为该股被低估，因为市场没有完全欣赏该公司的后期管道。”</blockquote></p><p></p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bristol Myers Stock Keeps Skidding on FDA Heart Drug Review<blockquote>百时美施贵宝股价因FDA心脏药物审查而持续下滑</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBristol Myers Stock Keeps Skidding on FDA Heart Drug Review<blockquote>百时美施贵宝股价因FDA心脏药物审查而持续下滑</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Street</strong><span class=\"h-time small\">2021-11-20 09:33</span>\n</p>\n</h4>\n</header>\n<article>\n<p>$Bristol Myers Squibb&nbsp;(<b>BMY</b>)$&nbsp;shares fell Friday after the pharmaceutical titan said the FDA has extended its review of heart drug mavacamten for three months, until April 28.</p><p><blockquote>$百时美施贵宝(<b>BMY</b>)$股价周五下跌，此前这家制药巨头表示FDA已将心脏药物mavacamten的审查延长三个月，直至4月28日。</blockquote></p><p> The drug treats symptomatic obstructive hypertrophic cardiomyopathy (oHCM).</p><p><blockquote>该药物治疗症状性梗阻性肥厚型心肌病（oHCM）。</blockquote></p><p> The Food and Drug Administration notified Bristol Thursday of the extension “to allow sufficient time to review information pertaining to updates to the proposed Risk Evaluation Mitigation Strategy (REMS),” the company said.</p><p><blockquote>该公司表示，美国食品和药物管理局周四通知布里斯托尔延期，“以便有足够的时间审查与拟议风险评估缓解策略（REMS）更新相关的信息”。</blockquote></p><p> “A REMS program was included in the initial application for mavacamten. No additional data or studies have been requested.”</p><p><blockquote>“mavacamten的初始申请中包含了REMS计划。没有要求额外的数据或研究。”</blockquote></p><p> Bristol Myers recently traded at $58.07, down 1.6%. It has slid 14% over the past three months.</p><p><blockquote>百时美施贵宝近期交易价格为58.07美元，下跌1.6%。过去三个月下跌了14%。</blockquote></p><p> “We are confident in the profile of mavacamten,” said Samit Hirawat, chief medical officer, global drug development at Bristol Myers.</p><p><blockquote>百时美施贵宝全球药物开发首席医疗官Samit Hirawat表示：“我们对mavacamten的前景充满信心。”</blockquote></p><p> “This first-in-class cardiac myosin inhibitor demonstrated clinically meaningful improvements in symptoms, functional status, and quality of life in symptomatic oHCM patients in the pivotal EXPLORER-HCM trial.”</p><p><blockquote>“在关键的EXPLORER-HCM试验中，这种一流的心肌肌球蛋白抑制剂在有症状的oHCM患者的症状、功能状态和生活质量方面表现出了具有临床意义的改善。”</blockquote></p><p> Mavacamten represented the top potential drug of MyoKardia, which Bristol Myers acquired last year for $13.1 billion, MarketWatch reports.</p><p><blockquote>据MarketWatch报道，Mavacamten是MyoKardia最具潜力的药物，百时美施贵宝去年以131亿美元收购了该药物。</blockquote></p><p> Morningstar analyst Damien Conover puts fair value for Bristol Myers at $68.</p><p><blockquote>晨星分析师Damien Conover认为百时美施贵宝的公允价值为68美元。</blockquote></p><p> “Bristol Myers hosted an investor day highlighting a strong pipeline that holds the potential to offset the firm’s major patent losses over the next decade, a key element supporting our wide moat rating,” he wrote in a commentary Tuesday.</p><p><blockquote>他在周二的评论中写道：“百时美施贵宝举办了投资者日活动，强调了强大的产品线，有可能抵消该公司未来十年的重大专利损失，这是支持我们宽护城河评级的关键因素。”</blockquote></p><p> “With most of the updates focused on still risky early-stage pipeline assets, the updates didn’t move our fair value estimate. However, we continue to view the stock as undervalued with the market not fully appreciating the firm’s late-stage pipeline.”</p><p><blockquote>“由于大多数更新都集中在仍然有风险的早期管道资产上，因此这些更新并没有改变我们的公允价值估计。然而，我们仍然认为该股被低估，因为市场没有完全欣赏该公司的后期管道。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/investing/bristol-myers-heart-drug-mavacamten-gets-extended-fda-review\">The Street</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMY":"施贵宝"},"source_url":"https://www.thestreet.com/investing/bristol-myers-heart-drug-mavacamten-gets-extended-fda-review","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111549440","content_text":"$Bristol Myers Squibb (BMY)$ shares fell Friday after the pharmaceutical titan said the FDA has extended its review of heart drug mavacamten for three months, until April 28.\nThe drug treats symptomatic obstructive hypertrophic cardiomyopathy (oHCM).\nThe Food and Drug Administration notified Bristol Thursday of the extension “to allow sufficient time to review information pertaining to updates to the proposed Risk Evaluation Mitigation Strategy (REMS),” the company said.\n“A REMS program was included in the initial application for mavacamten. No additional data or studies have been requested.”\nBristol Myers recently traded at $58.07, down 1.6%. It has slid 14% over the past three months.\n“We are confident in the profile of mavacamten,” said Samit Hirawat, chief medical officer, global drug development at Bristol Myers.\n“This first-in-class cardiac myosin inhibitor demonstrated clinically meaningful improvements in symptoms, functional status, and quality of life in symptomatic oHCM patients in the pivotal EXPLORER-HCM trial.”\nMavacamten represented the top potential drug of MyoKardia, which Bristol Myers acquired last year for $13.1 billion, MarketWatch reports.\nMorningstar analyst Damien Conover puts fair value for Bristol Myers at $68.\n“Bristol Myers hosted an investor day highlighting a strong pipeline that holds the potential to offset the firm’s major patent losses over the next decade, a key element supporting our wide moat rating,” he wrote in a commentary Tuesday.\n“With most of the updates focused on still risky early-stage pipeline assets, the updates didn’t move our fair value estimate. However, we continue to view the stock as undervalued with the market not fully appreciating the firm’s late-stage pipeline.”","news_type":1,"symbols_score_info":{"BMY":0.9}},"isVote":1,"tweetType":1,"viewCount":510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":815053192,"gmtCreate":1630631685916,"gmtModify":1631891867591,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/815053192","repostId":"2164829818","repostType":4,"isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818119377,"gmtCreate":1630383027899,"gmtModify":1704959475747,"author":{"id":"3565930395680990","authorId":"3565930395680990","name":"TradeLegend","avatar":"https://static.tigerbbs.com/efcf72a8fc8d429f1da25c34e3db472a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565930395680990","authorIdStr":"3565930395680990"},"themes":[],"htmlText":"🤑","listText":"🤑","text":"🤑","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/818119377","repostId":"2163833181","repostType":4,"isVote":1,"tweetType":1,"viewCount":287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}